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Abstract 
Proteases play key roles in physiology and disease development due to their active role in 
the regulation of other proteins.  Understanding and characterizing the active site of 
relevant proteases provides information vital to the production of inhibitors and 
elucidates potential native substrates that may be affected by inhibitors.  Once the 
preferred sequence of the active site of a target protease, such as β-secretase (BACE1), 
has been defined, protease inhibitors can be created to treat or manage diseases such as 
Alzheimer’s disease (AD).   BACE1 is an aspartic protease that is overexpressed in the 
AD brain and is believed to initiate the AD disease pathway.  As such, it is a strong 
candidate for drug design.  However, chronic administration of BACE1 inhibitors could 
result in undesirable side effects due to the impairment of its ability to hydrolyze native 
substrates; therefore, the amino acid peptide sequence preferentially cleaved by BACE1 
needs to be characterized.  Not only will this indicate potential substrates that may be 
affected by BACE1 inhibition, it will also aid in the synthesis of viable inhibitors. 
Recently, a novel method for determing the cleavage sequence of proteases was reported.  
Proteomic identification of cleavage sites (PICS) is a method designed to accurately 
identify cleavage sequence preferences and neighbor interactions in the cleavage site that 
influence protease cleavage.  This method gives additional information with less bias 
than previous methods used to characterize protease active sites.  Multiple controls were 
used to confirm the validity of the procedure.  These controls demonstrated our ability to 
successfully identify the amino acid sequence preferences for well characterized 
proteases. We were thus able to confidently use PICS to obtain the sequence of amino 
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acids preferentially cleaved by BACE.  BACE1A has two noticeable characteristics for 
the amino acid sequence cleaved: aromatic amino acids are preferred in the P1 site and 
leucine is strongly preferred in P2’.  Other preferred amino acids are observed in the 
sequence, but not to the extent of P1 and P2’.  Neighbor interactions were also 
investigated.  Positive cooperativity resulted with leucine or valine in P3 and with 
phenylalanine or tyrosine in P1.  There were strong interactions between valine in P3 and 
phenylalanine in P1 and between tyrosine in P1 and valine in P2’.  Sequence preferences 
were also investigated for BACE2A, which exhibited both similarities and differences 
between BACE1A and BACE2A.  The next step in this research will be to use knowledge 
of the preferred cleavage sites to determine physiological substrates of BACE1A.  This 
will reveal more information about the natural function of BACE1A and identify 
potential side effects of its inhibition. 
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 Introduction 
 
Protease function and importance in biological systems 
 
Proteases are a complex class of enzymes that make up nearly 2% of the human 
proteome, including over 500 proteases and their homologs.  They vary in size, location 
of expression, and characteristics such as reaction mechanism and optimal conditions for 
activity.  Proteases cleave other proteins by recognizing a specific sequence of amino 
acids or a single amino acid.    
Proteases are separated into five classes based on their catalytic mechanism:  
aspartic, metallo, cysteine, serine, and threonine proteases.1–6  The majority of proteases 
belong in the metallo, serine, and cysteine protease classes.  Threonine and aspartic 
proteases are more specialized and less numerous.2  Each class of protease is defined by 
the active site catalytic residues, e.g., aspartic proteases contain two aspartate groups in 
the active site.  The subsite positions in the active site and the corresponding substrate 
sequence recognized by the protease are described by their position in relation to the 
scissile bond (the peptide bond cleaved by the active site of the protease) (Fig. 1).  Amino 
acid residues N-terminal of the scissile bond in the recognition sequence are labeled P1, 
P2, etc. while the C-terminal positions are indicated as ‘prime’ (P1’, P2’, etc.). 3,5  
Corresponding pockets that bind the substrate residues are labeled S, e.g., the S2 pocket 
on the enzyme consists of all of the atoms (and residues) that interact with the P2 residue.   
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As mentioned before, two active site aspartate residues are responsible for 
aspartic protease catalytic activity.  They employ a general acid-base mechanism to 
cleave peptide bonds.  One of the aspartic residues acts as a general acid, while the other 
acts as a general base, resulting in the observed peak activity at an acidic pH (4.6). 7,8  
The aspartate residue acting as a base accepts a proton from a water molecule.  The 
resulting hydroxyl ion then carries out a nucleophilic attack on the carbonyl carbon 
adjacent to the scissile bond, while the other aspartate residue donates a proton to the 
oxygen of the carbonyl carbon to yield a tetrahedral carbon intermediate.7,8  The two 
aspartate residues then reverse their function, with one aspartate donating a proton to the 
nitrogen of the amide bond, and the other aspartate accepting a proton from the newly 
formed hydroxyl group on the tetrahedral carbon adjacent to the scissile bond (Fig. 2).  
Cleavage of the peptide bond creates a new carboxyl terminus for one protein/peptide 
fragment and a new amino terminus for the other.   
 
NH COOH P4 P3 P2 P1 P’1 P’2 P’3 P’4 
Scissile Bond 
 
Figure 1:  Protease active site nomenclature.  The amino acids comprising the 
substrate sequence cleaved are labeled P or P’ depending on which side of the 
scissile bond they are positioned.  The scissile bond, the bond cleaved by the 
protease, is indicated by the red arrow.  The active site positions on the protease 
are labeled S or S’ depending on which side of the scissile bond they are 
positioned.  Both active site and substrate positions are numbered moving away 
from the scissile bond.3 
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Protease active sites can recognize a single amino acid or class of amino acid, or they can 
recognize a sequence of amino acids depending on the size and shape of the active site.5  
Trypsin is a serine protease that recognizes and cleaves substrates after arginine or 
lysine.1  While trypsin only discriminates based on the amino acid in P1, papain is a 
cysteine protease that recognizes and cuts within a recognition sequence of 7 amino 
acids.  Papain’s active site allows multiple amino acids in each of the 7 positions.1,5   
Active site-substrate interactions are determined by the amino acid sequence of the 
substrate that is recognized by the protease.  Being able to define this sequence enables 
synthesis of inhibitors and insight into potential substrates of the protease being 
investigated.9    
Proteases play a key role in disease development due to their active role in the 
regulation of other proteins and enzymes.  Overexpression, underexpression, or mutations 
of proteases result in disruptions of biological processes that are implicated in a variety of 
disorders. In 2000, 14% of human proteases were being pursued as pharmaceutical drug 
targets, and protease inhibitors have already been synthesized and used to treat 
 
Figure 2: This figure generated using ChemDraw depicts the acid-base mechanism used 
by BACE1 to cleave substrates. 7 The two aspartate residues (Asp32 and Asp228) in the 
active site of BACE1 catalyze the reaction. 
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cardiovascular disease, periodontitis, AIDS, thrombosis, cancer, and other disorders. 3,9,10  
Angiotensin-converting enzyme inhibitors have been used as a treatment for 
cardiovascular conditions for the past 20 years.3,11  Successful inhibition of these 
proteases underscores the importance of investigating proteases implicated in other 
diseases such as AD.   
Many proteases have multiple substrates; therefore, strong inhibition could 
interfere with a protease’s non-disease function resulting in side effects.  Conversely, 
weak inhibition could have little to no effect in treating the disease.   Therefore a more 
thorough understanding of active site-substrate interactions is important in understanding 
and developing treatments strong enough to treat different diseases while minimizing 
significant side effects.   
BACE1 protease activity and biological significance 
β-secretase cleaving enzyme 1 (BACE1) was identified in 1999 as a 501aa aspartic 
protease with a type-I transmembrane domain.  Its mRNA is predominantly expressed in 
the brain and pancreas.12–15  Type-I transmembrane proteases are single pass membrane 
proteases with a luminal or extracellular N-terminus and a cytoplasmic C-terminus. The 
extensive exctacellular N-terminal portion of BACE1 contains the active site.16  The 
crystal structure of BACE1 has been identified as shown in Fig. 3.   
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BACE1 has five known splicing isoforms resulting from alternative splicing of 
exons 3 and 4.  BACE1A is the full length isoform of 501aa.  The other four isoforms 
yield non frameshift deletions in mRNA splicing, with lengths of 476, 457, 455, and 432 
residues known as BACE1B, BACE1C,  BACE 455, and BACE1D, respectively.17–20 
The mRNA of all of these isoforms are expressed in vivo.19  Alternative splicing could 
negatively affect the activity of the isoforms, but experimental evidence suggests that 
they all are catalytically active (Johnson, unpublished).       
As mentioned, BACE1 is an aspartic protease with optimal activity at low pH 
values.21  Aspartic proteases have two aspartyl residues in the active site that use acid-
base catalysis to break peptide bonds.3,4  These aspartates can be seen in Fig. 4.  BACE1 
is primarily found in intracellular compartments where the acidic environment favors 
BACE1 cleavage of substrates.16,22   
 
Figure 3:  Crystal structure of BACE1A in complex with an inhibitor generated using 
PyMOL.  The inhibitor is shown in red (PDB: 1FKN). The two active site aspartate residues 
are shown in blue.   
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The most widely studied substrate for BACE1 is the amyloid precursor protein 
(APP) from which the amyloid-β (Aβ) peptides are derived.  When BACE1 and another 
protease, γ-secretase, cleave APP, they form 40 or 42aa peptides known as Aβ-peptides 
(Fig. 5).12  These peptides aggregate to form oligomers, which further aggregate to form 
plaques.  Amyloid plaques are one of the hallmark pathologies of Alzheimer’s disease 
(AD).   These peptides and their soluble oligomers are toxic to cells and are hypothesized 
to be directly responsible for some of the symptoms of AD.23  APP is also a natural 
substrate for a different protease, α-secretase, which does not lead to the formation of Aβ-
peptides (Fig. 5).  The processing of APP by BACE1 is minimal in humans without AD, 
while in brains of AD patients, BACE1 expression is upregulated.24,25  Though it is 
involved in the AD pathological pathway, it is likely that there are other native BACE1 
substrates in non-disease pathways.    
 
 
Figure 4:  The crystal structure of the BACE1A active site with an inhibitor bound generated 
using PyMOL.  The inhibitor is shown in red. The two active site aspartate residues are shown 
in blue.   
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Native BACE1 substrates are currently being studied to determine the potential 
side effects resulting from BACE1 inhibition.  All of the known substrates are 
transmembrane proteins.  BACE1 regulates the activity of neuregulin 1 (NRG1), 
involved in axonal myelination, the β-subunits of voltage gated sodium ion channels 
(Nav1), platelet selectin glycoprotein ligand 1 (PSGL-1), type II-2,6-sialytransferase 
(ST6Gal-1), and Jagged1 which regulates astrogenesis.22,26,27 Many of the substrates are 
involved in stress or injury response pathways in which BACE1 is upregulated.28   
Known APP mutations in the eight amino acid sequence identified as the              
β-secretase cut site increase processing by BACE1.29–31   Three of these mutations, 
known as the Swedish, Flemish, and London mutations, result in early onset AD.13,30–32  
 
β-secretase cleavage 
Amyloid-β Peptide 
Oligomers 
Aβ Plaques 
Membrane 
Amyloidogenic Pathway Non-Amyloidogenic 
Pathway 
Amyloid precursor protein 
α-secretase cleavage 
γ-secretase cleavage 
Soluble Peptide 
 
Figure 5:  BACE1 in the Alzheimer’s disease pathway.  Amyloid-β peptides are formed 
when the amyloid precursor protein is cleaved  first by BACE1, then by γ-secretase.  These 
peptides aggregate to plaques, which can be seen in the AD brain. Cleavage by α-secretase 
and γ-secretase results in non-amyloidogenic processing of APP. 
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Recenctly, a mutation in APP resulting in a change in the amino acid residue 
corresponding to the BACE1 P2’ site was identified that decreased the production of Aβ 
plaques.33  Since these mutations occur within the sequence targeted by BACE1, they 
indicate that BACE1 does show preference for certain amino acid sequences.  BACE1 
expression is upregulated in the brains of AD patients; therefore, moderate inhibition 
could, in theory, decrease Aβ peptide production without interfering with the interaction 
of BACE1 and its other substrates.     
BACE2 protease activity and biological significance 
BACE2 is also a membrane associated aspartyl protease and is the only known 
homolog of BACE1.   The amino acid sequences for the two proteases share 75% 
homology.34  BACE2 is expressed in the heart, kidney, prostrate, brain, and various 
peripheral tissues, but expression in the brain and peripheral tissues is low.35,36  BACE2 
also has three known splicing isoforms.  BACE2A is the full length isoform comprised of 
518aas.37  BACE2B occurs when exon 8 is deleted, and BACE2C occurs when exon 7 is 
deleted.35   
BACE2 has the ability to cleave APP, but was not originally implicated in AD 
due to its lack of expression in neurons.  The different expression patterns indicate that 
BACE2 would likely have different substrates than BACE1, but very few substrates have 
been identified and are not well understood.  It is interesting to note that the BACE2 gene 
is found in the Down’s critical region of chromosome 21, the chromosome that when 
present in triplicate leads to the formation of Down’s syndrome.35  Although studies have 
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also shown that BACE2 is influential in insulin receptor tracking, the specific function of 
BACE2 and its substrates is not well understood. 38     
Methods used to characterize BACE 
Proteases are often involved in disease pathways due to their regulatory activity.  
Characterizing active site−substrate interactions is important if the disease is to be 
understood and treated.  One method used to gain information about a protease is to 
determine its tissue expression.  Expression shows where putative substrates may be 
located, as proximity is an important consideration in protease-substrate interactions.  
Expression studies suggest that putative substrates for BACE1 would be within the brain, 
specifically neurons, and pancreas.13–15,39   
Another useful method to determine the function of a protease is to knock out the 
gene in a model organism and identify the phenotypic effects.  Though knocking out a 
gene gives some idea of the function of a protease, it does not identify the substrates or 
preferred cleavage sequence.  BACE1 deficient mice were small and hyperactive 
compared to wild-type mice, but otherwise they showed a relatively mild phenotype.40  
Once a fundamental understanding of a protease is established, additional in vitro and in 
vivo methods can be used to identify putative substrates, such as determining the peptide 
sequence cleaved and relating that to the proteins expressed in the same tissue as the 
protease.   
Several studies have been directed towards identifying the peptide sequence 
targeted by BACE1.  To obtain this data, synthetic octapeptide libraries were created.  
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This was done to understand the preferred amino acid sequence cleaved by BACE1, 
hopefully leading to identification of its native substrates as well as to an understanding 
of potential side effects that might result due to BACE1-targeting therapeutics.  In 2001, 
Turner and Tang did this by creating peptide libraries starting from the peptide sequence 
derived from the Swedish mutant of APP that results in early onset AD.  One amino acid 
in the sequence was varied while the other seven residues were kept constant.41,42  This 
method gave information about the individual amino acids preferred by BACE1 in each 
part of the sequence; however, it was of necessity biased because it used a set parent 
sequence.  It also was not able to factor in cooperation between or dependence on 
neighboring amino acids.  Though multiple amino acids were identified in each position, 
the sequence that was hypothesized to be preferentially cleaved by BACE1 was 
EIDL*MVLD, while the native APP sequence is EVKM*DAEF, and the Swedish 
mutation sequence, which results in enhanced cleavage by BACE1, is EVNL*DAEF.41,42   
Quantitative proteomics, specifically stable isotope labeling with amino acids in 
cell culture (SILAC) has been used to identify potential BACE1 substrates.  SILAC 
involves using at least two different cell cultures.  Heavy isotopes are used to grow one 
culture, and light isotopes are used to grow the other.  One cell culture is the control, 
while BACE1 is overexpressed in the other.  Protein differences between the two cultures 
can be identified using mass spectrometry to discover putative substrates.  More than 70 
putative substrates were identified.39  All of the substrates were membrane bound; with 
three being glycophosphatidylinositol (GPI) linked proteins.  This makes sense, because 
BACE1 is a membrane bound protein, and they would be in close proximity.  Several of 
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the substrates were confirmed in subsequent cell-based studies.39  One potential problem 
with this method is that BACE1 is overexpressed, which could lead to the identification 
of proteins that are only BACE1 substrates under these non-natural conditions.   
Proteomic identification of cleavage sites (PICS) is a recently described method 
designed to accurately identify cleavage sequence preferences and neighbor interactions 
in the cleavage site that influence protease cleavage (Fig. 6).  This method involves 
creating peptide libraries from organisms with known proteomes, cleaving the peptides in 
the library with the protease of interest and tagging the newly formed N-termini, isolating 
and sequencing the peptides corresponding to the original C-terminal (or prime side) 
sequences by mass spectrometry, and then determing the associated N-terminal peptide 
sequence through bioinformatcs database searching (Fig. 6).  PICS has been used 
successfully for other proteases and should be useful in determining the preferred 
cleavage sequence for BACE1.   
  12 
  
Peptide sequencing and Mass spectrometry  
Peptide sequencing was first accomplished in the 1950s, when Edman published 
his method termed ‘Edman degradation’.  Edman’s approach focused on cleaving 
individual amino acids sequentially from the N-terminus of a peptide, and then 
identifying the amino acid cleaved using chromatography.43  This approach was time-
consuming, as each cleavage was done individually.  Also, it did not work well if the    
N-terminus was modified or if the sample was not pure.  In the 1960’s, mass 
 SH 
NH2 
Proteome 
SH 
NH2 
Library Protease 
Digestion 
NH2 
NH2 
Peptide Library 
Amine Protection 
Sulfhydryl Protection 
NH2 
NH2 
NH2 
  
 
Biotinylation 
Streptavidin 
Affinity Column 
Mass Spectrometry Database  
BACE Digestion 
Peptide Library 
NH2 
SEQU - ENCE 
 
Figure 6:  Flowchart for the proteomic identification of cleavage sites method.  The 
proteome of an organism with a sequenced genome is isolated.  The proteome is used to 
make a peptide library, which can be cut by the protease of interest.  New N-termini are 
tagged with biotin, and isolated.  The prime peptide sequence is then determined 
through mass spectrometry, while the non-prime sequence can be found using database 
searching (figure adapted from ref 59).  
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spectrometry (MS) was first introduced as a new way to sequence peptides.  In the 1990s, 
mass spectrometry essentially replaced Edman degradation, because peptides did not 
need to be purified before sequencing, modified peptides could be analyzed, peptide 
fragmentation was much faster, and sensitivity was significantly better.44–46   
Mass spectrometry has become a powerful tool in peptide sequencing and 
proteomics, especially since the genome of many organisms have been sequenced.  Fig. 7 
illustrates the general process of peptide sequencing using mass spectrometry.  Most MS 
instruments that are used for peptide sequencing couple high performance liquid 
chromatography (HPLC) to the mass spectrometer.  This allows peptides to be separated 
before injection for samples with large numbers of peptides.  HPLC elutions can be 
directly ionized, and the ions can then be guided through the mass spectrometer. The 
peptides are fragmented within the mass spectrometer, and the mass to charge (m/z) 
ratios are detected.  This information is used to identify the sequence of the peptides.  The 
peptide sequence can then be matched to the organism’s proteome, and the original       
N-terminal or non-prime peptide sequence can be identified.   
   
 
m/z 
In
te
n
si
ty
 
Database Search Mass Spectrometry 
COOH 
Sequenced Peptide 
N-terminal  
Peptide Sequence 
Peptide Ionization HPLC 
 
Figure 7: The schematics for peptide sequencing.  Peptides are separated by size using 
high performance liquid chromatography (HPLC), and then ionized.  The peptide 
sequence is determined through mass spectrometry, and then the sequenced peptide is 
compared to the proteome through bioinformatic database searching to identify the N-
terminal sequence. 
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For peptide sequencing, mass spectrometers need to be tandem MS machines that 
convert the sample into gas phase ions, select precursor ions based on their mass to 
charge ratio in an ion trap (m/z), fragment the selected ions in a collision cell, and then 
detect the m/z ratios of the product ions (Fig. 8).  There are multiple mass analyzers that 
can be used to sequence peptides, such as the linear trap quadrupole (LTQ), time-of-flight 
(TOF), Fourier-transform ion cyclotron resonance (FT-ICR), and Orbitrap mass 
analyzers.  All of these machines are useful, however using multiple machines or ‘hybrid’ 
instruments can increase resolution even more. 
 
In order to enter the mass analyzer, peptides have to be ionized.  Electrospray 
ionization (ESI) is a soft ionization technique that brings peptides into the gas phase 
without fragmentation.  The sample is introduced to the ionization chamber through a 
tapered needle, which sustains a charge of a few kilovolts compared to the chamber, 
causing an electric field to be present at the needle’s tip.  This field creates a charge on 
the liquid surface, which causes the liquid to be electrostatically dispersed in a spray 
consisting of multiply charged droplets that are driven towards the mass analyzer.  The 
 
Detector Collision Cell 
HPLC 
Ionization 
Chamber 
Ion Trap 
m/z 
In
te
n
si
ty
 
 
Figure 8: Schematic of a Mass Spectrometer. Peptides are separated by size using 
HPLC, and then they are ionized within an ionization chamber.  The peptide ions enter 
an ion trap where a single m/z ratio is selected.  That peptide ion enters the collision cell, 
where it is fragmented.  The fragment m/z ratios are detected and used to identify the 
peptide sequence. 
  15 
conditions within the chamber combine to speed evaporation of the droplets.  This 
reduces the size of the droplets, while increasing their charge density.  This creates 
instability within the droplet, making the droplet explode.  This reaction is repeated until 
ions are desorbed into the gas phase (Fig. 9).44,45  As tryptic peptides are most commonly 
used in peptide sequencing, the ions created are generally doubly protonated, though the 
ions can become multiply charged if they are large.45   
 
Individual peptide ions of a specific m/z ratio are selected, and then that peptide is 
fragmented to obtain its sequence.47  One fragmentation technique is collision-induced 
dissociation (CID), which can be performed at low energies.45  In this approach, an inert 
gas, such as nitrogen or argon, is used to fragment the selected peptide ions by collision.  
The gas molecules collide with the precursor ions and impart energy, which causes the 
precursor ion to fragment into product ions.45  These ions are then scanned in the mass 
analyzer to produce product ion scans, though scans of fragments less than 7 amino acids 
long are not analyzed, because they are not very informative.45  This technique does have 
limitations; pertinent information is hard to obtain with large, multiply charged peptides, 
glycosylated and phosphorylated peptides.44  
 Peptide 
 
Figure 9: ESI:  The peptides in solution are run through a needle with a slightly higher 
charge than the surroundings.  The liquid is thus electrostatically dispersed, which 
creates multiply charged droplets. The solvent evaporates, which reduces the size of the 
droplets.  This increases the charge density, and sample ions are created due to 
desorption.59    
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Bn and yn ions (with n = 1, 2, 3, etc.) are the most common ions produced; 
however, other ion cleavage products can be produced as well (Fig. 10).  Bn ions are the 
N-terminal amide bond cleavage product, and yn ions are the C-terminal amide bond 
cleavage product.  Fragmentation patterns depend on multiple variables, including the 
amino acid arrangement, peptide size, and time scale of the instrument used.49   When a 
peptide is fragmented into its b and y ions, the structure of the peptide can be determined 
using bioinformatics and database searching.44   
There are multiple reaction pathways for the fragmentation of peptides.   Charge-
remote peptide fragmentation pathways (PFPs) and other ions are formed by the loss of 
water or ammonia. 49  In some cases, side chain reactions also occur.  These reactions can 
compete with the b-y ion reactions, but for the most part, these reactions do not 
predominate.50  The PFP of most interest for general peptide sequencing generates the 
charge-directed sequence bn-yn ions.  The formation of these ions can be described by 
what is known as the ‘mobile proton’ model, where the proton on precursor ions can 
migrate between protonation sites, unless there is a basic amino acid, in which case, the 
 
Figure 10: Nomenclature of peptide fragmentation: b and y ions are the most common, 
as they are produced in CID.  These fragments are created when the peptide bond is 
broken.48     
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proton stays on the basic amino acid.50,51   The site of protonation is also the cleavage site 
in charge-directed pathways, because the protonation helps facilitate the cleavage 
reaction.52  All of the PFPs are in competition, which leads to different information 
appearing in the mass spectra.  The most important and informational pathways create b 
and y ions.  These fragments result in sequence information that can be used to determine 
the primary structure of peptides.  
The newest mass analyzer is the Orbitrap.  The Orbitrap uses only electrostatic 
fields to confine and analyze ions.53  This machine is a very powerful tool in proteomics, 
specifically peptide sequencing.  It is a relatively low cost machine that combines high 
resolving power, sensitivity, dynamic range, and mass accuracy.  When this mass 
analyzer is coupled to LTQ, it creates a valuable blend of the LTQ and Orbitrap 
capabilities, mainly the sensitivity and MS/MS capacity of the LTQ, and the high mass 
accuracy and resolution power of the Orbitrap.54  The LTQ-Orbitrap is capable of greater 
than 150,000 mass resolution and mass accuracy measurements of less than 2 ppm when 
measuring mixtures of multiple peptides.53,54  In this machine, ionized peptides are 
directed to the LTQ, which is a linear ion trap.  The precursor ions are scanned, and 
precursor ions with the selected m/z ratio are trapped while all other ions are expelled.  
The selected ions are fragmented through CID and sent to the C-trap, which injects the 
ions into the Orbitrap in a pulsed manner. 
The Orbitrap is composed of two electrodes, a barrel-shaped outer electrode and a 
spindle-shaped inner electrode.53 A DC voltage applied between the two electrodes 
creates an electrostatic potential distribution, which traps ions.  Ions with stable 
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trajectories can be detected, while ions with unstable trajectories are not detected.  Ions 
with stable trajectories orbit around the inner electrode and move axially along the z-axis.  
Motion along the z-axis can be described as simple harmonic oscillation.  The frequency 
of axial oscillations is only dependent on the mass and charge of the ions.  The axial 
motion is therefore used in detection, as it is only dependent on the ions themselves.  This 
characteristic is the reason for the Orbitrap’s high resolution and mass accuracy.53  Axial 
motion of the ions induces an image current in the outer electrodes.  This current is 
acquired as a ‘time-domain transient’ and Fourier-transform is used to create a frequency 
spectrum.53  The resulting spectrum is then converted to a corresponding m/z ratio 
spectrum.   
Once the peptide fragmentation spectra have been acquired, further work is 
required to determine the peptide sequences.  Bioinformatics resources are used to 
perform these analyses.  The bioinformatics software suites use algorithms and statistics 
to correctly assign sequence identification to mass spectra.  In the PICS procedure, only 
organisms with sequenced genomes are used to create the peptide libraries.  Once the C-
terminal peptide sequence is sequenced, it can be matched to the original protein through 
database searching to identify the upstream sequence.   
Experimental Procedures 
This procedure has been modified from the PICS procedure outlined by Schilling 
and Overall (Fig. 6).55   Protease libraries were created by growing cell lines of two 
sequenced genomes, E. coli or Drosophila melanogaster.  The cells were lysed to release 
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the proteome, which was then digested with one of three proteases:  trypsin, 
chymotrypsin, or GluC.  The new peptides were modified chemically to avoid disulfide 
bonding and to mask existing amino groups and N-termini, resulting in a peptide library.  
This library was cleaved by the protease of interest, and new N-termini were biotinylated 
and then purified by chromatography using a streptavidin column to isolate all the 
biotinylated peptides.  These peptides were sequenced by mass spectrometry and used to 
search the proteome to determine the entire sequence that was preferentially cleaved by 
the protease of interest. 
Protease Library Creation 
Cell growth 
 Two different cell lines were used for the described studies:  E. coli DH5α and 
Drosophila melanogaster Schneider 2 cells (S2).   
DH5α 
E. coli DH5α cells were grown in 5 mL Luria broth (LB) at 37 oC for 12-14 hours. 
This was used to inoculate 300 mL of LB broth, which was grown to an optical density of 
0.4-0.6 at 37 °C.  Once the cells reached the desired density, they were centrifuged at 
400xg for 20 min at 4 °C.  The cell pellet was washed with 5 mL of 1x PBS and 
centrifuged using the same settings.   The PBS wash and centrifuge step were repeated.     
S2 
Drosophila S2 cells were cultured and grown in Express 5 Serum Free medium 
(Gibco) containing 16 mM L-glutamine (SFM). S2 cells were grown at 28 oC in a 75mm2 
flask. They were then scaled up to 400 mL of SFM in a shaking incubator at 28 oC and 
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grown for 3-4 days.  Once the cells reached the desired density, they were centrifuged at 
400xg for 20 min at 4 °C.  The cell pellet was washed with 5 mL of 1x PBS and 
centrifuged using the same settings.   The PBS wash and centrifuge steps were repeated.     
Cell lysis 
DH5α 
The cells were first re-suspended in 20 mL of lysis buffer (10mM HEPES pH 7.5, 
10 mM EDTA, 1 mM PMSF, 10 μM E-64).  Repeated cycles of ultrasonication (Fisher 
Scientific Sonic Dismembrator Model 500) were used to lyse the cells on ice.  DH5α 
cells were lysed at 55% sonication 10 times for 10 seconds with 20 second breaks in 
between.  The sample was then centrifuged for 20 min at 20,000xg at 4 °C.     
S2 
The cells were first re-suspended in 20 mL of lysis buffer (10 mM HEPES pH 
7.5, 10 mM EDTA, 1 mM PMSF, 10 μM E-64).  Repeated cycles of ultrasonication 
(Fisher Scientific Sonic Dismembrator Model 500) were used to lyse the cells on ice.  S2 
cells were lysed at 40% sonication 10 times for 5 seconds with 15 second breaks in 
between.   
Proteome modification and precipitation 
DH5α and S2 
The resuspended peptide solution was adjusted to a final concentration of 
100 mM HEPES and 5 mM DTT.  This was incubated at 25 °C for 1 hour.  The 
concentration of iodoacetamide in solution was adjusted to 20 mM.  This was incubated 
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at 25 °C for 1 hour.  Again, the concentration of DTT in solution was adjusted to 5 mM 
(total concentration of 10 mM) and incubated at 25 °C for 15 min.  Then, the 
concentration of trichloroacetic acid (TCA) was adjusted to 15% and the sample was 
incubated on ice for 1hr. 
Protease library creation 
DH5α  
The sample was centrifuged at 20,000xg for 20 min at 4 °C.  The protein pellet 
was washed twice with 1 mL of chilled methanol and then air-dried for 5 min.  The 
protein pellet was re-suspended with 5 mL of 20 mM NaOH.  The sample was sonicated 
if necessary to completely re-suspend protein.  Once the protein was re-solubilized, the 
concentration of the solution was adjusted to 200 mM HEPES (pH 7.5).  The sample was 
centrifuged at 20,000xg for 10 min at 4 °C.  The protein concentration was determined 
using a micro Bradford assay.  One of three proteases (trypsin, chymotrypsin, or GluC) 
was added at a 1:100 (mass/mass) ratio of protease to library.  The digestion was 
incubated for 16 hrs at 37 °C.  
S2 
The sample was centrifuged at 20,000xg for 20 min at 4 °C.  The protein pellet 
was washed twice with 1 mL of chilled methanol and then air-dried for 5 min.  The 
protein pellet was re-suspended with 15 mL of 20 mM NaOH.  The sample was sonicated 
on ice for 1 hr at 35% sonication.  Once the protein was re-solubilized, the concentration 
of the solution was adjusted to 200 mM HEPES (pH 7.5).  The sample was centrifuged at 
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20,000xg for 10 min at 4 °C.  The protein concentration was determined using a micro 
Bradford assay.  One of three proteases (trypsin, chymotrypsin, or GluC) was added at a 
1:100 (mass/mass) ratio of protease to library.  The digestion was incubated for 16 hrs at 
37 °C.  
Acetylation of cysteine residues  
DH5α and S2 
Protease activity was stopped with 1 mM PMSF and 1M guanidine hydrochloride, 
and the sample was centrifuged at 20,000xg for 10 min at 4 °C.  The concentration of 
DTT in solution was adjusted to 5 mM, and the sample was incubated for an additional 
hour at 37 °C.  The concentration of iodoacetamide was added to a final concentration of 
40 mM, and the sample was incubated at 37 °C for 1.5 hr.  The concentration of DTT in 
solution was adjusted to 15 mM (total concentration of 20 mM) followed by a 10 min 
incubation.  The concentrations of formaldehyde and sodium cyanoborohydride in 
solution were adjusted to 30 mM incubated for 2 hrs.  This step was repeated for a total 
concentration of 60 mM formaldehyde and sodium cyanoborohydride, and the sample 
was incubated for 16 hrs. 
Size exclusion chromatography of peptide library  
The concentration of the solution was adjusted to 100 mM glycine, and the 
sample was incubated at 25 °C for 0.5 hr.  Two G10 columns (GE) arranged in tandem 
were equilibrated with 10 mM sodium phosphate and 20% acetonitrile (pH 2.7).  The 
system was connected to an Äkta FPLC system monitoring the absorbance at 280 nm 
(A280) and the conductivity vs. mL loaded plot in real time.  The sample was loaded and 
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washed with the buffer until an increase in A280 was observed.   Fractions were collected 
until an increase in conductivity was observed.  The acetonitrile was removed by vacuum 
evaporation.  The samples were acidified to 0.5% trifluoroacetic acid and degassed by 
applying mild vacuum.  The libraries were purified by C18 solid-phase extraction using 
the manufacturer’s protocol with an elution solution of 80% acetonitrile (Thermo 
Scientific).  A volume of 3 mL was used for all wash, elution, and sample loading steps.  
The peptide concentration was determined using a BCA assay.  Acetonitrile was removed 
from the samples by vacuum evaporation until the solution reached a concentration of 
1.5-2 mg/mL.  The samples were aliquoted into 200 μg peptide libraries. 
Cleavage site sequence determination  
Peptide library cleavage and product isolation 
The concentration of sodium acetate (pH 4.5) in the peptide libraries was adjusted 
to 20 mM with 1 M sodium acetate (pH 4.5), and the peptide library concentration was 
adjusted to 1 mg/mL.  BACE1 or BACE2 was added in a ratio of protease to library 
between 1:50 and 1:1,000 (mass/mass).  The digestion was incubated for 16 hr at 37 °C.  
The protease was deactivated by heating the sample at 80 °C for 20 min.  The new N-
termini were biotinylated by adding 0.5 mM sulfo-NHS-SS-biotin (Pierce, Inc.), and the 
sample was incubated for 2 hrs at 25 °C.   
Half a milliliter of high capacity streptavidin-Sepharose resin (GE) was 
equilibrated in a spin column with a 10 μm filter with buffer (50 mM HEPES, 150 mM 
NaCl, pH 7.5).  All spin steps were performed at 200xg for 1 min.  The sample was added 
to the resin and incubated at 22 °C for 30 min, then centrifuged.  The eluent was 
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reapplied, and the centrifuge step repeated.  The flow-through was discarded and the 
column was washed 10 times with 0.5 mL of buffer (50 mM HEPES, 150 mM NaCl, pH 
7.5).  The sample was incubated with the elution buffer, 0.5 mL (50 mM HEPES, 20 mM 
DTT, pH 7.5), for 1 hr at 25 °C.  The sample was centrifuged, and the eluent was 
collected.  The elution step was repeated, and the two elution fractions were pooled.  
Another C18 solid-phase extraction was performed as earlier, but with an elution buffer 
of 80% acetonitrile and 0.1% TFA.  The sample was dried down with vacuum 
evaporation, and the sample was sent to the Center for Mass Spectrometry and 
Proteomics at the University of Minnesota, St. Paul campus for mass spectrometric 
analysis with the LTQ Orbitrap Velos.   
Mass Spectrometry and Database Analysis 
LTQ-Orbitrap settings and database search parameters 
The standard settings for Orbitrap peptide analysis were used.  CID and single 
charge mode specifications were used.   
The data analysis was performed using software available through MSI, the TINT 
Proteomics Software pipeline (https://tint.msi.umn.edu/).  An integrated identification 
workflow was used to start SEQUEST searches to analyze the raw mass spectrometric 
data (Fig 11).   
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The integrated identification workflow contained multiple windows with options 
for different parameters (Figs. 11-14).  This workflow gave options for the different 
parameters that were chosen.  Fig. 12 illustrates how to select the sample, the database, 
and start the database search using SEQUEST.   
A        B 
  
Figure 11:  This figure showed the TINT website.  A) An integrated identification workflow was 
started. B) An existing TINT peak list was chosen.   
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The main search parameters for the integrated identification workflow are shown 
in Fig. 13.  Here a peptide and fragment tolerance of 1 amu, maximum number of 
cleavage sites as 1, and tryptic search limited to C-termini for all tryptic libraries were 
chosen (Fig. 13A).  There were three fixed amino acid modifications due to the chemical 
modifications introduced during the procedure:  cysteine (57.0215), lysine (28.0313), and 
A              B 
   
C            D 
   
Figure 12:  Four of the windows in the integrated identification workflow on TINT were shown.  A)  The 
samples of interest were uploaded.  B)  The output name and parent folder for the samples were 
entered.  C)  MSI SEQUEST was the only search program option.  D)  The database necessary for the 
sample was entered.   
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the N-terminal amino acid (87.9983) (Fig. 13 B).  There was one variable amino acid 
modification: methionine (15.994915) (Fig. 13 C).  For any library made with 
chymotrypsin or GluC, a partial no enzyme search was used (Fig. 13 D).  
 
A             B 
  
C              D 
   
Figure 13:  The integrated identification workflow parameter options were displayed here.  A)  This was 
the main set of parameters to choose from.  B)  Fixed modifications for amino acids were entered in this 
window.  C)  The variable modifications for amino acids were entered in this window.  D)  This set of 
parameters was used for any library that was not created with trypsin.   
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The final three windows in the integrated identification workflow were shown in 
Fig. 14.  They apply to Scaffold, which was a viewing program.  There was only one 
choice of viewing program (Fig. 14A).  In the next window, two different options were 
used.  For individual samples, ‘one scaffold analysis per identification analysis’ was 
chosen.  For multiple search results, then ‘all identification analyses as one scaffold 
sample’ was chosen (Fig. 14B).   The parameters in the final window could be changed 
when the search output file was opened in Scaffold (Fig. 14C).     
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Once the samples were run through the SEQUEST search program, they were 
opened in Scaffold (Fig. 15).  Settings of min. protein of 80%, min. # peptides 2, and 
min. peptide of 90% were chosen.  Then the peptide report was exported as an Excel file.  
   
A           B 
     
C 
  
Figure 14:  The final windows in the integrated identification workflow were shown.  A) There was 
only one option here:  choose Scaffold.  B)  Either view individual samples or multiple samples added 
together.  C)  These options were for the scaffold viewing program and were changed in the scaffold 
program.   
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The peptide list was pasted into the CLIP-PICS website:  
http://clipserve.clip.ubc.ca/pics/cgi/PICS.cgi 
The analysis tab was opened and the peptide list was uploaded.  The sample was 
named, and the protease and organism used to create the library were chosen.  Subsite 
cooperativity was analyzed for all samples (Fig. 16).  
 
Figure 15:  This was the Scaffold program that showed optimal settings for exporting the 
peptide list.   
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Results 
Control optimization: Tryptic DH5α library cut with GluC    
Two different protease-to-library ratios were used to cut tryptic DH5α libraries 
with GluC, a very specific protease that only cuts after acidic amino acids.  Parameters 
 
 
Figure 16:  This was the Analysis page on the CLIP-PICS website.  To obtain data from the Mass 
Spectrometric analysis, the peptide list from Scaffold was uploaded, the protease and organism 
used to generate the peptide library were chosen, and substrate cooperativity was analyzed 
(http://clipserve.clip.ubc.ca/pics/cgi/PICS.cgi).   
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were optimized using a sample created at a 1:100 GluC:Library ratio (Table 1-8).  This 
information was used to optimize search parameters so that greater than 95% of the 
correct peptides were selected.56  Many search programs are available, each using a 
different algorithm to identify peptides.  The level of error is measured differently for 
each method.  All of the programs matched the raw Orbitrap sequencing data to amino 
acid sequences in the sequenced proteome used to generate the peptide library. This 
allowed us to determine the original amino acid sequence cut by the protease of interest. 
The parameters optimized were: enzyme search specifications, the level of error allowed, 
and whether the modifications occurring with the PICS procedure were fixed or variable.  
The enzyme specification could be tryptic, semi-tryptic or non-specific.  These affect the 
results by setting limits on the database search.  Setting tryptic enzymatic specificity 
caused the search program to compare our mass spectrometer sequencing data with a 
hypothetical tryptic digest of the organism used.  This decreased the length of the search; 
however, the tradeoff is that some peptides could be missed due to the constraints.  Our 
goal was to minimize the search time while maximizing the number of peptides 
identified. 
In the PICS procedure, there were three separate modifications made to the 
peptide libraries:  carboxyamidomethylation of cysteine, dimethylation of lysine, and 
thioacylation of the N-termini.55  Thioacylation had to be a fixed modification, as this 
was what identified the peptides cleaved by the protease of interest.  The other two 
modifications may or may not have been present in all of the peptides.  Therefore, fixed 
and variable modifications were tested for each method.  Two different methods were 
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optimized and compared to determine which one performed better for this data.  The two 
different methods were:  SEQUEST search data viewed with Scaffold and SEQUEST 
search data run through the Trans-Proteomic Pipeline (TPP) with Peptide Prophet.  
SEQUEST was the first search program to be optimized because it was the most 
straightforward and fastest method, and it was available free of charge through the 
University of MN.  Scaffold is a viewing program that is used to both view the 
SEQUEST data and set the percent false discovery rate (FDR) that was used for the 
fragment data.  The second method also used SEQUEST; however, the next step was to 
put the SEQUEST data through another search program, TPP.  TPP is an online data 
analysis pipeline for processing mass spectrometric data.  Peptide Prophet was the most 
important step in TPP for this data as it validates data from other search programs, such 
as SEQUEST.  The peptides identified using these different methods were uploaded onto 
the website, CLIP-PICS (http://clipserve.clip.ubc.ca/pics/),  specifically designed for the 
PICS procedure.57  This website matched the list of peptides with the proteome of the 
peptide library and the protease used to cut the peptide library.  These data were used to 
re-validate the peptides and list the information in tables.  
Two scaffold parameters were optimized using SEQUEST parameters of partial 
tryptic enzyme specification, fixed modifications on lysine and cysteine, and peptide and 
fragment tolerance of 1 amu: minimum peptide and minimum protein threshold tolerance, 
These optimal values gave 80% protein and 90% peptide matches. Of the 241 peptides 
identified, 95.4% of the peptides had glutamate or aspartate in P1, matching GluC 
specificity (Table 1).  80% protein match means that 80% of the sequenced peptide 
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matched a protein from the organism’s proteome.  90% peptide match means that 90% of 
the sequenced peptide identified with a peptide from the program’s hypothetical cleavage 
of the proteome.   
 
Scaffold was also optimized using the same tryptic DH5α library with a 1:100 
GluC:Library ratio with double the amount of the control run through the Orbitrap.  The 
results in Table 2 agree with those in Table 1; a threshold of 80% for proteins and 90% 
for peptides gave the best values for total number of peptides and for the number of 
peptides.  Of the 272 peptides identified 97.8% matched the known GluC specificity.  
The scaffold parameters for both runs of the sample were the same.  An 80% match for 
proteins and a 90% match for the peptides gave a large percent error; however, later steps 
revalidated the identified peptides, which allowed us to be confident that the peptides 
were cleaved by the protease of interest and were relevant.   
Table 1: A tryptic DH5α library was cut with GluC as a control to optimize Scaffold 
parameters.  The parameters that yielded the most peptides without losing specificity 
were 80% protein and 90% peptide thresholds.   
 
Scaffold  optimization for Sample 3 
Probability threshold Protein_Peptide 80_80 80_90 80_95 
# of Peptides 269 241 215 
% Match 94.8 95.4 95.8 
Probability threshold Protein_Peptide 90_90 90_95 95_95 
# of Peptides 232 215 118 
% Match 95.7 95.8 95.8 
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The various SEQUEST parameters were optimized using the control to determine 
which parameters resulted in the highest number of peptides matching the specificity of 
GluC cleavage: glutamate or aspartate in P1.  The parameters that were optimized 
included:  enzyme search specifications, peptide and fragment tolerance in atomic mass 
units (amu), and fixed or variable amino acid modifications.  All other SEQUEST 
parameters were left in their default settings in accordance with the recommendation of 
Dr. LeAnn Higgins, the research assistant professor responsible for operating the LTQ 
Orbitrap Velos at the Center for Mass Spectrometry and Proteomics at the University of 
Minnesota.  The results of these optimization searches can be seen in Table 3.  The 
parameters that gave the best results were peptide and fragment tolerance of 1 amu, 
C-terminal tryptic enzymatic search, and fixed modifications for lysine, cysteine, and the 
N-termini.  These parameters resulted in 243 peptides, 96.3% of which had the GluC 
preferred glutamate (E) or aspartate (D) in P1. 
Table 2:  A tryptic DH5α library was cut with GluC as a control to optimize Scaffold 
parameters.  Double the amount of sample was run through the mass spectrometer 
compared to the sample in Table 2.  The parameters that yielded the most peptides 
without losing specificity were 80% protein and 90% peptide thresholds.   
 
Scaffold  optimization for Sample 3_50 
Probability threshold Protein_Peptide 80_80 80_90 80_95 
# of Peptides 287 272 243 
% Match 97.2 97.8 98.3 
Probability threshold Protein_Peptide 90_90 90_95 95_95 
# of Peptides 263 243 149 
% Match 98.1 98.3 98.6 
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The same sample was run through the Orbitrap at double the concentration.  
Optimization searches were run to confirm the results; however, a fragment tolerance of 
Table 3:  A tryptic DH5α library was cut with GluC as a control.  Sequest search parameters were 
optimized.  The most peptides were found using a fragment tolerance of 1amu.  The search parameters that 
gave the highest percent of matching peptides and the most peptides was a C-terminal tryptic digest with a 
peptide and fragment tolerance of 1 amu..   
 
SEQUEST Data Optimization for Tryptic DH5α Library cut with GluC with Sample 3 
SEQUEST Search 
Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment 
Tolerance (amu) 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 241 189 178 247 177 180 237 175 170 
% Matching Peptides 95 95.3 96.6 94 94.4 95 95 96 96.5 
SEQUEST Search 
Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment 
Tolerance 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 243 193 180 244 191 182 244 182 178 
% Matching Peptides 94.2 94.8 95 94.2 93.7 94.5 94.3 93.9 94.9 
SEQUEST Search 
Specification Non-specific digest with variable modification 
Peptide/Fragment 
Tolerance (amu) 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 233 172 167 230 173 167 219 155 145 
% Matching Peptides 95.3 94.8 94 94.8 94.8 94.6 95.4 95.5 94.5 
SEQUEST Search 
Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment 
Tolerance (amu) 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 241 182 172 243 182 192 229 174 164 
% Matching Peptides 95.4 96.1 97.1 94.7 96.1 96.5 95.6 95.9 95.7 
SEQUEST Search 
Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment 
Tolerance (amu) 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 243 197 189 249 196 179 241 183 164 
% Matching Peptides 96.3 95.9 96.2 94.8 95.9 95.5 95.8 95.1 95.7 
SEQUEST Search 
Specification Non-specific digest with fixed modification 
Peptide/Fragment 
Tolerance (amu) 1_1 1_1.5 1_2 1.5_1 1.5_1.5 1.5_2 2_1 2_1.5 2_2 
# of Peptides 242 190 171 250 185 171 226 161 163 
% Matching Peptides 93.8 93.6 93.5 94.4 94.6 93.5 94.7 95.1 95.7 
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1 amu was used (Table 4).  More peptides were identified in all cases due to the higher 
concentration of sample being run through the mass spectrometer.  There was not a single 
set of parameters that yielded the best results in all cases, so the optimized parameters 
from the original sample, C-terminal tryptic digest with a peptide and fragment tolerance 
of 1 amu, were chosen for all subsequent tryptic DH5α library samples.  For the 50x 
tryptic DH5α library cut with GluC, 279 peptides were identified 97.1% of which had E 
or D in P1 once again consistent with the preference of GluC , confirming the validity of 
the method.  A second set of parameters gave similar results; the non-specific enzyme 
specification with fixed modifications and peptide and protein tolerance of 1 amu were 
also considered to be optimal parameters for this sample.   
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Once the optimization for SEQUEST search parameters was completed, TPP 
parameters were optimized using the second set of mass spectrometric data with double 
the amount of sample loaded.  The best search results from SEQUEST, C-terminal tryptic 
digest with a peptide and fragment tolerance of 1 amu was used to optimize the enzyme 
specification, peptide length, probability cut-off, and Peptide Prophet parameters.  
Tryptic and semi-tryptic searches resulted in the same peptide list (Table 5).  There was 
no difference between the two searches; therefore, the semi-tryptic was the parameter 
setting used for all subsequent searches.  Probability represents the percent error allowed.  
Table 4: A tryptic DH5α library was cut with GluC as a control run at double the concentration 
compared to Table 2.  SEQUEST search parameters were optimized.  The most peptides were found 
using a fragment tolerance of 1.   
 
SEQUEST Data Optimization for Tryptic DH5α Library cut with GluC with Sample 3-50x 
SEQUEST Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 273 275 271 
% Matching Peptides 97.9 97.5 97 
SEQUEST Search Specification 
C-terminal Tryptic digest with variable 
modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 277 275 270 
% Matching Peptides 97.5 97.5 97.1 
SEQUEST Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 270 266 255 
% Matching Peptides 94.8 96.6 96.5 
SEQUEST Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 272 274 270 
% Matching Peptides 97.8 97.1 97.1 
SEQUEST Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 279 275 268 
% Matching Peptides 97.1 97.4 97.7 
SEQUEST Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 281 279 264 
% Matching Peptides 96.8 96.4 97.3 
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While values of 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, and 0.1 were 
evaluated, only three of these values are shown in Table 5.  The optimal value was 0.08, 
which allowed for an error of 8%.  The shortest peptide of 7 resulted in the best data.  
Finally, three different Peptide Prophet parameters were optimized: choosing to not use 
isotope-coded affinity tagged (icat) data, not using the number of missed cleavages 
(NMC), and using accurate mass binning.  These settings did not result in a significantly 
different number of peptides that matched the expected amino acids of E or D. 
 
After the TPP parameters had been optimized, SEQUEST searches were run 
through TPP using the optimized parameters to refine the SEQUEST parameters used in 
TPP for the original mass spectrometric data (Table 6).  A fragment tolerance of 1 amu is 
shown.  Several searches were run with other fragment tolerances, but they resulted in 
fewer peptides and lower percentages of matching peptides.  The SEQUEST parameters 
Table 5: A tryptic DH5α library cut with GluC was used as a control to optimize parameters 
for SEQUEST and TPP. The optimal parameters were semi-tryptic enzyme specification, 
0.08 probability cut-off, peptide length of 7, and default Peptide Prophet settings.   
 
TPP Parameter Optimization for Sample 3_50x 
TPP Protease Search  Tryptic Semi -Tryptic Non-specific 
# of Peptides 182 182 192 
% Match  87.9 87.9 85.4 
TPP Probability  0.06 0.08 0.1 
# of Peptides 182 181 180 
% Match  87.9 88.4 88.4 
TPP Peptide length 6 7 8 
# of Peptides 201 181 159 
% Match  87 88.4 88 
Peptide Prophet no icat Accurate mass no NMC 
# of Peptides 182 187 187 
% Match  88.5 87.1 87.7 
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resulting in the highest number of peptides with E or D in P1 were non-specific enzyme 
specification with a peptide tolerance of 1.5 amu (Table 6).  However, using a peptide 
tolerance of 1 amu, the difference between the two sets of parameters was only 4 peptides 
or 0.1%. Both fixed and variable modifications gave similar results, but fixed 
modifications had a slightly higher percent of matching peptides.   The set of parameters 
used for all further samples was: peptide tolerance of 1.5 amu, fixed modifications, and 
non-specific enzyme specification (Table 6).  This set of parameters yielded 226 peptides, 
92.5% containing E or D in the P1 position.   
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The TPP parameters were optimized using the same sample run through the 
Orbitrap at double the concentration to confirm the results.  The results were similar, with 
non-specific enzyme parameters yielding the best results; however, variable 
modifications resulted in a significantly larger number of peptides than for any other set 
of parameters (Table 7).  There was not one set of parameters that was significantly better 
Table 6: A tryptic DH5α library cut with GluC was used as a control to optimize parameters for 
SEQUEST and TPP. The optimal parameters were non-specific enzyme specification with a peptide 
tolerance of 1.5 and a fragment tolerance of 1.   
 
TPP Data Optimization for Tryptic DH5α Library cut with GluC for Sample 3 
SEQUEST Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 183 199 196 
% Matching Peptides 90.2 86 86.9 
SEQUEST Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 176 219 217 
% Matching Peptides 90.9 80.4 82 
SEQUEST Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 219 230 221 
% Matching Peptides 91.8 90 91.4 
SEQUEST Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 178 196 199 
% Matching Peptides 92.2 89.1 87 
SEQUEST Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 225 215 222 
% Matching Peptides 79.1 71.9 79.3 
SEQUEST Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 222 226 285 
% Matching Peptides 92.4 92.5 88 
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than the others, though non-specific enzyme specification, fragment tolerance of 1.5 amu, 
and variable modifications for K and C yielded the highest number of peptides (287) with 
greater than 90% of those peptides matching the specificity of GluC.   
 
Once all of the search methods had been optimized, the results were compared to 
determine the best search method for identifying peptides within our data sets (Table 8).  
The SEQUEST/Scaffold optimized method was used to analyze tryptic DH5α libraries 
Table 7:  A tryptic DH5α library cut with GluC was used as a control to optimize parameters for 
SEQUEST and TPP.  The optimal parameters were non-specific enzyme specification with a peptide 
tolerance of 1 and a fragment tolerance of 1.   
 
TPP Data Optimization for Tryptic DH5α Library cut with GluC for Sample 3_50x 
SEQUEST Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 175 172 173 
% Matching Peptides 90.3 91.8 91.4 
SEQUEST Search Specification 
C-terminal Tryptic digest with variable 
modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 181 178 178 
% Matching Peptides 88.4 91 91 
SEQUEST Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 281 287 209 
% Matching Peptides 90 91 89.5 
SEQUEST Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 169 167 166 
% Matching Peptides 91.7 93.4 93.4 
SEQUEST Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 183 173 174 
% Matching Peptides 88.6 91.9 92.5 
SEQUEST Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 202 201 265 
% Matching Peptides 94.1 92.7 89.8 
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cut with the protease of interest, due to the larger percentage of peptides matching GluC 
cleavage specificity. 
 
The CLIP-PICS website designed by Overall and Schilling was used to re-
validate and create heat maps to visualize the data.  Heat maps for each of the 2 methods 
of analysis were created (Figure 17).  The only amino acids for which there is a 
preference in P1 are E and D.  These samples all display the specificity of GluC, once 
again confirming that the PICS method can be confidently used to obtain information 
about the amino acid sequence preferentially cleaved by the protease of interest. 
 
 Table 8:  A tryptic DH5α library cut with GluC was used to optimize 
parameters for several data analysis methods.  The method that yielded the 
most peptides with the highest percent match for GluC specificity was using the 
SEQUEST search program combined with the Scaffold viewing program.   
 
Optimal Search Parameters for Sample 3_50x 
TPP Scaffold 
# of Peptides 287 279 
% Match 91 97.1 
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The group who wrote the PICS method also analyzed a tryptic library cut with 
GluC as a control.56  They found that a 1:100 ratio of GluC : Library yielded more than 
290 peptide sequences with greater than 94% matching the expected specificity for GluC.  
Also, a 1:1000 ratio of GluC : Library yielded over 400 peptides with greater than 94% 
matching the expected specificity for GluC.  Our 1:100 sample yielded a similar number 
of peptides with a higher percent matching the expected values.  However, our sample 
with a 1:1000 ratio of GluC:Library yielded very few peptides and is not shown here.   
Control optimization: Tryptic DH5α library cut with chymotrypsin 
Two different protease-to-library ratios were used to cut tryptic DH5α libraries 
with chymotrypsin.  The ratios were 1:100 and 1:1000 for chymotrypsin to library 
(μg/μg).  Parameters were optimized using both of these control samples (Tables 9-15).  
Chymotrypsin is a less specific protease than GluC.  It cleaves amino acid sequences 
A       B 
 
      
 
Figure 17:  The CLIP-PICS website was used to create heat maps to visualize the analysis of 
the tryptic DH5α library cut with GluC in a 1:100 ratio of protease to Library. Heat maps for 
each of the two methods used are shown here.   All three methods yielded over 250 peptides.  
A)  The Sequest/Scaffold method had greater than 97% selectivity for E and D in P1.  B)  The 
Sequest/TPP method had greater than 90% selectivity for E and D in P1.   
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following large hydrophobic amino acids: phenylalanine, tyrosine, tryptophan, and 
leucine.58  Using this protease as a control, we can optimize the parameters that lead to 
the identification of the most peptides with a significant portion (~65%) of the amino 
acids matching chymotrypsin specificity.   
Multiple methods using SEQUEST as the database search program were used to 
gain the most information from our samples.  The first method used SEQUEST as the 
database search engine, and then used Scaffold to view the peptide list at a certain 
probability threshold.  The Scaffold probability threshold was optimized using 
SEQUEST parameters of non-specific enzyme search, fixed modifications on lysine and 
cysteine, and protein and peptide tolerances of 1 amu (Table 9).  The optimal probability 
threshold was 80% protein tolerance and 90% peptide tolerance.  These are large 
tolerances; however, there is a subsequent validation that increases the level of 
confidence.  These tolerance levels were used for all of the SEQUEST optimization tests.   
 
Once the Scaffold parameters were optimized, multiple SEQUEST parameters 
were tested and optimized (Table 10 and 11).  The enzyme search specification options 
Table 9:  A tryptic DH5α library cut with chymotrypsin was used to optimize the Scaffold probability 
threshold.  The protein and peptide probability thresholds yielding the most peptides with the highest 
percent of matching peptides were 80% and 90%, respectively.   
 
Scaffold  optimization for tryptic DH5α cut with chymotrypsin in a 1:1000 ratio 
Probability threshold Protein_Peptide 80_80 80_90 80_95 
# of Peptides 292 261 231 
% Matching Peptides 67.8 68.9 71.4 
Probability threshold Protein_Peptide 90_90 90_95 95_95 
# of Peptides 255 231 137 
% Matching Peptides 69.8 71.4 73.7 
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were: partial tryptic digestion, C-terminal tryptic digestion, and non-specific digestion.  
These options were tested with fixed and variable modifications as well as differing 
peptide and protein tolerance levels.  The optimal values for a protease to library ratio of 
1:100 were non-specific digestion with fixed modifications and protein and peptide 
tolerance of 1 amu (Table 10).  The optimal parameters for SEQUEST resulted in 118 
peptides, with 54.2% of those peptides having F, W or Y in the P1 position, consistent 
with the cleavage specificity of chymotrypsin.   
 
Table 10:  A tryptic DH5α library cut with chymotrypsin was used as a control to optimize parameters 
for SEQUEST and Scaffold.  The optimal parameters were non-specific enzyme specification, fixed 
modifications, and a peptide and fragment tolerance of 1 amu.    
SEQUEST Data Optimization for Tryptic DH5α Library cut with Chymotrypsin with a 1:100 
ratio 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 72 102 89 
% Matching Peptides 47.2 8.9 49.4 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 147 120 120 
% Matching Peptides 29.9 39.1 39.1 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 110 103 95 
% Matching Peptides 44.6 54.4 56.9 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 83 86 85 
% Matching Peptides 53 55.8 53 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 130 119 118 
% Matching Peptides 37.7 41.1 41.6 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 118 107 107 
% Matching Peptides 54.2 52.3 53.3 
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The SEQUEST parameters were also optimized using a protease to library ratio of 
1:1000.  The optimal parameters for this control were again non-specific enzyme search 
specifications, fixed modifications and a protein and peptide tolerance of 1 amu (Table 
11).  This set of parameters matched the optimized parameters for the 1:100 
protease:library ratio.  It also matched the second set of previously optimized parameters 
for the tryptic DH5α library cut with GluC (Table 3 and 4).  The optimal parameters 
resulted in 261 peptides, 68.9% of which had F, W or Y in the P1 position corresponding 
to the known chymotrypsin cleavage preference.   
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Once the controls had been optimized for SEQUEST/Scaffold parameters, the 
TPP method was optimized.  The control with a ratio of 1:100 was used to optimize TPP 
parameters for a SEQUEST search with fixed modifications, non-specific enzymatic 
specifications, and protein and peptide tolerances of 1 amu (Table 12).  The optimal TPP 
parameters were a semi-tryptic enzyme specification with a probability threshold of 0.08.  
These parameters were the same as those identified for the tryptic GluC library (Table 5).   
Table 11:  A tryptic DH5α library was cut with chymotrypsin as a control to optimize the SEQUEST 
parameters with Scaffold.  The optimal parameters were non-specific digestion, fixed modifications, 
and a peptide and fragment tolerance of 1 amu.   
 
SEQUEST Data Optimization for Tryptic DH5α Library cut with Chymotrypsin with a 1:1000 
ratio 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 210 98 209 
% Matching Peptides 67.2 20.4 69.9 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 260 240 240 
% Matching Peptides 56.6 64.1 64.1 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 222 233 236 
% Matching Peptides 68.5 68.2 69.9 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 213 209 211 
% Matching Peptides 70 72.2 71.1 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 271 262 255 
% Matching Peptides 60.5 62.6 63.2 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 261 251 252 
% Matching Peptides 68.9 69.4 70.2 
 
  49 
 
After the TPP parameters were optimized, SEQUEST searches were performed 
using the best parameters.  As seen for the tryptic DH5α GluC control, the optimal 
enzymatic specification was non-specific. The optimal parameters for the 1:100 of 
protease to library control were also fixed modifications with a peptide and fragment 
tolerance of 1 amu (Table 13).   These parameters agreed with those for sample 3 (Table 
6).  They also agreed with those for sample 3 run at double the concentration (Table 7).  
The best set of parameters resulted in 101 peptides, 61.4% of which had F, W, or Y in the 
P1 position, which is consistent with the cleavage preference of chymotrypsin.   
Table 12:  A tryptic DH5α library was cut with chymotrypsin as a control to optimize the TPP 
parameters.  The optimal parameters were semi-tryptic cleavage with a probability of 0.08.   
 
Optimization of TPP parameters with a ratio of 1:100 
Enzyme specification Tryptic Semi tryptic Nonspecific 
# of peptides 112 112 53 
% matching peptides 57.1 57.1 69.7 
TPP probability threshold 0.03 0.05 0.08 
# of peptides 139 112 101 
% matching peptides 49.7 57.1 61.4 
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TPP parameters were also optimized using a 1:1000 ratio of chymotrypsin to 
tryptic DH5α library.  The optimal parameters were non-specific enzyme specification 
with fixed modifications and a peptide and fragment tolerance of 1 amu (Table 14); the 
same as those for the 1:100 ratio (Table 13).  The optimal parameters resulted in 327 
peptides, 64.9% of which displayed chymotrypsin cleavage preference. 
Table 13:  A tryptic DH5α library cut with chymotrypsin was used to optimize TPP parameters.  The 
optimal parameters were non-specific enzyme constraints with fixed modifications and a peptide and 
fragment tolerance of 1 amu.   
 
TPP Data Optimization for Tryptic DH5α Library cut with Chymotrypsin with a ratio of 1:100 
Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 54 62 71 
% Matching Peptides 64.7 9.7 57.7 
Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 80 77 94 
% Matching Peptides 46.3 54.6 47.8 
Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 79 51 125 
% Matching Peptides 62.1 64.7 48 
Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 65 62 72 
% Matching Peptides 60 64.5 59.7 
Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 67 75 99 
% Matching Peptides 61.3 54.7 47.5 
Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 101 113 125 
% Matching Peptides 61.4 59.3 48 
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Once the 2 controls cleaved with chymotrypsin had been optimized, the different 
methods were compared to determine the best method for analyzing tryptic DH5α sample 
cleaved by our protease of interest (Table 15).  Analysis with TPP resulted in similar 
percentages of matched peptides for both samples.  Further samples were analyzed using 
SEQUEST/Scaffold, as this method was determined to be better for the tryptic DH5α 
Table 14:  A tryptic DH5α library cut with chymotrypsin was used to optimize the TPP parameters.  The 
optimal parameters were non-specific enzyme specification with fixed modifications and a peptide and 
fragment tolerance of 1 amu.   
 
TPP Data Optimization for Tryptic DH5α Library cut with Chymotrypsin with a ratio of 1:1000 
Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 179 59 237 
% Matching Peptides 68.7 23.8 66.3 
Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 201 297 318 
% Matching Peptides 61.8 54.2 51.9 
Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 298 315 324 
% Matching Peptides 64.2 65.2 65.4 
Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 204 236 238 
% Matching Peptides 69.6 65.2 66.4 
Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 236 298 321 
% Matching Peptides 61.1 54.6 51.1 
Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 327 344 322 
% Matching Peptides 64.9 62.5 61.9 
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libraries cut with GluC, and neither method showed a significant difference for these 
tryptic DH5α libraries cut with chymotrypsin. 
 
Following optimization of parameters for the tryptic DH5α library cut with GluC, 
heat maps were generated to visualize the data.  All of the heat maps show that amino 
acids matching chymotrypsin cleavage predominate in P1 (Figure 18).   
Table 15:  A tryptic DH5α library cut with chymotrypsin was used to 
optimize parameters for several data analysis methods.   
 
Optimal Search Parameters 
  TPP Scaffold 
  26 27 26 27 
# of Peptides 101 327 118 261 
% Matching Peptides 61.4 64.9 54.2 68.9 
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Figure 18:  A DH5α library cut with chymotrypsin was used as a control to validate the PICS method.  
Multiple database search methods were tested to determine the best method for identifying peptides cleaved 
by the protease of interest and heat maps were generated to visualize the data.  For all heat maps 
corresponding to the analysis of the chymotrypsin control samples, the observed amino acid preferences 
are consistent with the established chymotrypsin cleavage preferences.  A)  A 1:100 chymotrypsin to DH5α 
library was optimized using SEQUEST and Scaffold.  B)  A 1:100 chymotrypsin to DH5α library was 
optimized using SEQUEST and TPP.  C) A 1:1000 chymotrypsin to DH5α library was optimized using 
SEQUEST and Scaffold.  D)  A 1:1000 chymotrypsin to DH5α library was optimized using SEQUEST and 
TPP.   
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Control optimization: Tryptic S2 library cut with GluC 
Two different protease-to-library ratios were used to cut tryptic S2 libraries with 
GluC.  The ratios were 1:100 and 1:1000 for chymotrypsin to library.  Parameters were 
optimized using both of these controls (Tables 16-22).  Again, the fact that GluC is a very 
specific protease was used to optimize search parameters such that only greater than 95% 
of the correct peptides were identified.56  Multiple methods testing different database 
search programs were used, so that we could be sure to gain the most from our samples.  
The first method used SEQUEST as the database search engine, and then used Scaffold 
to view the peptide list at a certain probability threshold.  The Scaffold probability 
threshold was optimized using SEQUEST parameters of non-specific enzyme search, 
fixed modifications on the amino acids, lysine and cysteine, protein tolerance of 1.5 amu 
and peptide tolerances of 1 amu (Table 16).  The optimal probability threshold was 80% 
protein tolerance and 80% peptide tolerance.   
 
The optimized Scaffold probability thresholds were then used to find the best 
SEQUEST parameters for the tryptic S2 controls cut with GluC.  Non-specific enzymatic 
Table 16:  A tryptic S2 library cut with GluC was used to optimize the parameters for 
Scaffold.  The optimal parameters resulting in the most peptides with the highest percentage 
matching GluC specificity were 80%  probability thresholds for both protein and peptide 
tolerance.   
 
Scaffold  optimization for Sample 25 
Probability threshold Protein_Peptide 80_80 80_90 80_95 
# of Peptides 870 835 793 
% Matching Peptides 94.7 94.6 94.8 
Probability threshold Protein_Peptide 90_90 90_95 95_95 
# of Peptides 687 646 646 
% Matching Peptides 94.8 95 95 
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constraints resulted in the most peptides and the highest number of peptides matching 
GluC specificity.  Fixed modifications with a peptide tolerance of 2 amu increased the 
number of peptides identified (Table 17).  These parameters resulted in 1183 peptides, 
with 91.3% of the peptides consistent with the expected GluC cleavage preference.   
 
Once the 1:100 ratio of GluC to tryptic S2 library was optimized, the 1:1000 ratio 
was used to confirm the best parameters.  Again, non-specific search constraints with 
Table 17:  A tryptic S2 library cut with GluC was used to optimize the parameters for SEQUEST.  The 
optimal parameters for a SEQUEST search were non-specific enzyme specifications with fixed 
modifications and a peptide tolerance of 2amu.   
 
SEQUEST Data Optimization for Tryptic S2 Library cut with GluC for 1:100 ratio 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 90 89 89 
% Matching Peptides 78.9 79.8 83.1 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 114 104 97 
% Matching Peptides 66.6 74.1 81.5 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 768 1121 1168 
% Matching Peptides 91.1 91.4 91.9 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 93 92 89 
% Matching Peptides 83.9 82.6 85.4 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 115 113 110 
% Matching Peptides 68.7 69 72.7 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 1173 1175 1183 
% Matching Peptides 91.1 91.3 91.3 
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fixed modifications and a peptide tolerance of 2 amu yielded the best results (Table 18).  
These parameters resulted in 880 peptides, 94.6% of which had E or D in the P1 position. 
 
After the parameters for the first database search method were optimized, 
parameters for the second method were optimized.  The TPP parameters were optimized 
using non-specific enzyme constraints with variable modifications and a peptide and 
Table 18:  A tryptic S2 library cut with GluC was used to optimize the parameters for SEQUEST.  The 
optimal parameters for a SEQUEST search were non-specific enzyme specifications with fixed 
modifications and a peptide tolerance of 2 amu.   
 
SEQUEST Data Optimization for Tryptic S2 Library cut with GluC for 1:1000 ratio 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 65 72 67 
% Matching Peptides 81.6 79.2 80.6 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 81 86 81 
% Matching Peptides 70.4 72.1 75.3 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 542 720 753 
% Matching Peptides 93.4 94.1 94.1 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 71 76 75 
% Matching Peptides 80.3 78.9 78.7 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 89 100 96 
% Matching Peptides 68.6 66 66.7 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 851 870 880 
% Matching Peptides 94.5 94.7 94.6 
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fragment tolerance of 1 for the SEQUEST parameters.  The optimal parameters for TPP 
were non-specific enzyme specification with a probability threshold of 0.08 (Table 19).  
 
The optimal TPP parameters were used to optimize the SEQUEST parameters.  
The best parameters were non-specific enzyme specification, fixed modifications, and a 
peptide and fragment tolerance of 1 amu (Table 20).  These parameters resulted in 1624 
peptides, 88.3% of which had E or D in the P1 position.   
Table 19:  A tryptic S2 library cut with GluC was used to optimize parameters for TPP.  
The optimal parameters were non-specific enzyme specification and a probability 
threshold of 0.08. 
 
Optimization of TPP parameters Sample 24 
Enzyme specification Tryptic Semi tryptic Nonspecific 
# of Peptides 2037 2037 1735 
% Matching Peptides 80.5 80.5 86.4 
TPP probability threshold 0.03 0.05 0.08 
# of Peptides 2172 2037 1917 
% Matching Peptides 77.3 80.5 83.4 
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After optimizing TPP and SEQUEST parameters for the 1:100 ratio of GluC to 
tryptic S2 library, the same parameters were optimized using a 1:1000 ratio control.  The 
optimal parameters were the same as those for the 1:100 ratio:  non-specific enzyme 
constraints, fixed modifications, and a peptide tolerance of 1 amu (Table 21).  These 
parameters resulted in 974 peptides, with 92.1% of those peptides consistent with the 
cleavage preference of GluC.   
Table 20: A tryptic S2 library cut with GluC was used to optimize SEQUEST and TPP parameters.  
The optimal parameters were non-specific enzyme constraints, fixed parameters, and a peptide and 
fragment tolerance of 1 amu.   
 
TPP Data Optimization for Tryptic DH5α Library cut with Chymotrypsin Sample 24 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 85 87 88 
% Matching Peptides 82.3 85 87.5 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 87 79 90 
% Matching Peptides 71.3 88.6 83.4 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 938 1579 1727 
% Matching Peptides 88.4 84 82.5 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 78 84 90 
% Matching Peptides 89.8 85.7 84.5 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 74 85 100 
% Matching Peptides 83.8 85.8 78 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 1624 1831 1878 
% Matching Peptides 88.3 84.7 84.1 
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Once the parameters had been optimized for both database searches, the methods 
were compared to determine the best set of parameters to use for S2 libraries cut with our 
protease of interest, BACE1.  Scaffold identified fewer peptides for both S2 controls; 
however, the percentage of peptides matching GluC cleavage was higher for both S2 
controls (Table 22).  Therefore, the SEQUEST/Scaffold search method was used for all 
further S2 samples.  
Table 21:  A tryptic S2 library cut with GluC was used to optimize SEQUEST and TPP parameters.  The 
optimal parameters were non-specific enzyme constraints, fixed parameters, and a peptide and fragment 
tolerance of 1 amu.   
 
TPP Data Optimization for Tryptic DH5α Library cut with Chymotrypsin Sample 25 
Enzyme Search Specification Partial Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 47 57 55 
% Matching Peptides 93.6 89.5 92.7 
Enzyme Search Specification C-terminal Tryptic digest with variable modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 45 55 53 
% Matching Peptides 84.5 83.7 86.8 
Enzyme Search Specification Non-specific digest with variable modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 567 970 1109 
% Matching Peptides 92.9 86.1 83.3 
Enzyme Search Specification Partial Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 48 52 57 
% Matching Peptides 93.8 94.2 94.8 
Enzyme Search Specification C-terminal Tryptic digest with fixed modifications 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 43 48 53 
% Matching Peptides 95.4 93.8 92.5 
Enzyme Search Specification Non-specific digest with fixed modification 
Peptide/Fragment Tolerance (amu) 1_1 1.5_1 2_1 
# of Peptides 974 1185 1254 
% Matching Peptides 92.1 86.2 84.4 
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Heat maps for each of the S2 controls and each of the database search methods 
were generated.  In these heat maps, the only amino acids that apppear in P1 are E and D 
(Figure 19).  These peptides are the only ones that should appear after cleavage by GluC.   
Table 22:  The optimal search parameters for a tryptic S2 library cut with GluC 
were compared to determine the best database search method.   
 
Optimal Search Parameters 
  TPP Scaffold 
  24 25 24 25 
# of Peptides 1624  974 1183 880 
% Matching Peptides 88.3  92.1 91.3 94.6 
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Tryptic DH5α library cut with BACE1A 
A tryptic DH5α library was cut with BACE1A to determine the sequence of 
amino acids preferentially cut by this protease.  Multiple ratios of protease to library were 
A       B 
    
C      D 
     
 
Figure 19:  An S2 library cut with GluC was used as a control to validate the PICS method.  Multiple 
database search methods were tested to determine the best method for identifying peptides cleaved by the 
protease of interest and heat maps were generated to visualize the data.  For all of the panels, the only 
amino acids appearing in this heat map are those corresponding to GluC cleavage.  A)  A 1:100 GluC to 
S2 library was optimized using SEQUEST and Scaffold.  B)  A 1:100 GluC to S2 library was optimized 
using SEQUEST and TPP.  C) A 1:1000 GluC to S2 library was optimized using SEQUEST and Scaffold.  
D)  A 1:1000 GluC to S2 library was optimized using SEQUEST and TPP.   
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used to determine the ratio resulting in the most peptides (Table 23).  A ratio of 
approximately 1:50 yielded the highest number of peptides.   
 
Heat maps were generated by pooling the peptide results for the best samples:  2, 
22, 41 and 45.  311 peptides were used to generate the heat map. Cleavage site 
preferences for BACE1A were aspartate (D) in P4, isoleucine (I) in P3, aromatic residues 
(Y and F) or hydrophobic residues (L)  in P1, methionine (M) in P1’ and valine (V) in 
P2’ (Fig. 20).    
Table 23: A tryptic DH5α library was cut with BACE1A.  Different ratios of protease to 
library were used to determine the best ratio.  A ratio of 1:50 resulted in the highest 
number of peptides.   
 
Sample Id 
# 
Protease:Library 
Ratio # of Scaffold Peptides 
# of TPP 
Peptides 
1 125 29 0 
2 36 116 151 
19 17 18 2 
20 8 24 12 
21 4 31 0 
22 50 132 171 
23 200 24 0 
34 100 25 0 
41 50 71 4 
42 50 55 8 
43 151 34 15 
44 300 38 14 
45 56 57 85 
47 47 67 8 
48 47 13 0 
46.5 50 76 63 
47.5 110 48 28 
48.5 200 45 0 
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Neighbor effects for BACE1A cleavage sites were analyzed (Table 24, Figure 21, 
and Figure 22).  The largest degree of cooperativity existed between P3 and P1.   
 
 
 
Figure 20:   A tryptic library was used to create this heat map. The heat map shows the amino 
acids that preferentially comprise the cleavage site for BACE1A. There are not any amino acids 
with high specificity outside of P3 or P3’. 311 peptides were analyzed to generate this heat map.  
The most important amino acids here appear to be the aromatic residues in P1 and valine in P2’. 
 
Table 24:  Potential subsite cooperativity is shown for BACE1A. Neighbor effects do not appear to a 
large extent. The largest cooperativity influence is between P3 valine and P1 phenylalanine.  P1 refers 
to the N-terminal side of cleavage starting with the amino acid closest to the cleavage site.  P1’ refers to 
the C-terminal side of cleavage starting with the amino acid closest to the cleavage site (Fig. 1). 
 
Fixed residue Affected residue Change (%) % Occurrence Fixed Residue 
P3_L  P1_N  11.6 13.2 
P3_V  P1_F  21.2 10.3 
P3_V  P2_E  14.7 10.3 
P1 Y P2’ V  13.9 9 
P1_F  P3’ Q  20 10 
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When tyrosine is in P1, there was a marked preference for valine in P2’.  This was 
seen with phenylalanine in P1, but it was not as intense (Fig. 21). There was also a 
preference for serine in P2.  With phenylalanine in P1, there was a strong preference for 
valine in P3 and glutamine in P3’.   
 
With valine in P3, there was a marked preference for phenylalanine in P1.  This 
preference was not seen with isoleucine or leucine in P3.  There was also a preference for 
glutamate in P2 (Fig. 22).  When leucine was in P3, there was a slight preference for 
asparagine in P1.  No strong neighbor effects were observed with isoleucine in the P3 
position. 
A     B 
   
 
Figure 21:  Heat maps depicting neighbor effects for fixed amino acids in P1. A) With tyrosine in P1, 
there was an increase in the preference for valine in P2’. B) The strong preference for valine was not 
seen with phenylalanine in P1, but an increase in the preference for valine in P3 was observed. 
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Chymotrypsin DH5α library cut with BACE1A 
A chymotrypsin DH5α library was cut with BACE1A to reinforce the tryptic 
library data.  Multiple ratios of protease to library were used to determine the ratio 
resulting in the most peptides (Table 25).  The optimal ratio appeared to be between 1:50 
and 1:100.  
A       B 
 
   
C 
 
 
Figure 22:  Heat maps depicting neighbor effects for fixed amino acids in P3. The largest neighbor 
effect occurs when valine was in P3. A) With isoleucine in P3, there were no noticeable neighbor 
effects. B) With leucine in P3, there was an increase in the preference for asparagine in the P1 
position.  C) With valine in P3, there was an increase in the preference for phenylalanine in P1. 
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A heat map was generated by pooling the identified peptide sequences from the 
best 2 samples, 28 and 29 (Fig. 23).  72 peptides were analyzed to create the heat map.  
The amino acids that were most prominent were methionine (M) in P4, glutamine (Q) in 
P2, methionine (M) or cysteine (C) in P1, glycine (G) in P2’, and tryptophan (W) in P4’.   
 
 
Table 25:  A chymotrypsin DH5α library was cut with BACE1A.  Different ratios of protease to 
library were used to determine the best ratio.  A ratio of between 1:50 and 1:100 resulted in the 
highest number of peptides. 
 
Sample Id #  Protease : Library Ratio # of TPP Peptides # of Scaffold Peptides 
5 1:250 22 32 
28 1:90 54 38 
29 1:40 29 34 
35 1:100 8 16 
36 1:125 9 21 
 
    
 
 
Figure 23:  A heat map was created for chymotrypsin DH5α libraries cut with BACE1A.  72 unique 
peptides were analyzed to determine that M was preferred in P4, Q was preferred in P2, M or C were 
preferred in P1, G was preferred in P2’, and W was preferred in P4’.   
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GluC DH5α library cut with BACE1A 
A GluC DH5α library was cut with BACE1A to determine the sequence of amino 
acids preferentially cut by BACE1A.  Multiple ratios of protease to library were used to 
determine the ratio resulting in the most peptides (Table 26).  The optimal ratio appeared 
to be greater than 1:20. 
 
A heat map was generated using the 2 best samples.  84 unique peptides were 
analyzed to create the heat map, which identified tryptophan (W) in P4, W in P3, 
histidine (H) in P2, W or serine (S) in P1, glycine (G) or W in P1’, M or I in P2’, and 
tyrosine (Y) in P4’ (Fig. 24).   
Table 26:  GluC DH5α libraries were cut with BACE1A using multiple ratios of protease to library to 
determine the optimal ratio for each sample set.  A ratio of greater than 1:20 appeared to be optimal. 
 
Sample Id # Ratio of Protease : Library # of Scaffold Peptides # of TPP Peptides 
16 1:9 4 0 
17 1:9 3 0 
30 1:20 48 16 
31 1:10 38 59 
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Tryptic S2 cut with BACE1A 
Multiple tryptic S2 libraries were cleaved with BACE1A at different protease to 
library ratios (Table 27).  Several ratios resulted in higher numbers of peptides.  The best 
ratios appeared to be between 1:150 and 1:300; however, ratios of 1:50 and 1:25 also 
yielded similar numbers of peptides.   
 
 
Figure 24:  A heat map was generated for GluC libraries cut with BACE1A.  84 peptides were analyzed 
to determine the noticeable amino acids:  W in P4, W in P3, H in P2, W or S in P1, G or W in P1’, and 
M or I in P2’.   
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A heat map was generated using the 4 best tryptic S2 libraries cut with BACE1A 
(Fig. 25).  110 unique peptides were analyzed.  The amino acids that occurred at higher 
than natural abundance were W or Y in P2, S in P1, S in P1’, and M in P4’.   
 
 
Table 27: Tryptic S2 libraries were cut with BACE1A at several protease to library ratios.  The best 
ratios appeared to be between 1:150 and 1:300; however ratios of 1:25 and 1:50 resulted in similar 
numbers of peptides.   
 
Sample Id # Ratio of Protease : Library # of Scaffold Peptides # of TPP Peptides 
15 1:14 9 0 
32 1:50 21 10 
33 1:25 21 18 
37 1:100 11 6 
38 1:125 13 0 
39 1:150 36 3 
40 1:300 41 4 
 
    
 
 
Figure 25:  A heat map was generated for 4 tryptic S2 libraries cut with BACE1A.  Amino acids 
occurring at higher than natural abundance were W or Y in P2, W in P1, S in P1’, and M in P4’.  
110 peptides were used in the analysis.   
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Tryptic DH5a cut with BACE2A 
Two tryptic DH5α libraries were cut with BACE2A at different ratios of protease 
to library (Table 28).  The two ratios resulted in a similar number of peptides, but there 
were not many peptides for either.   
 
A heat map was generated using both tryptic DH5α libraries cut with BACE2A.  
57 unique peptides were analyzed (Fig. 26).  The peptides occurring at higher than 
natural abundance were M in P4, W in P2, F or D in P1, P or M in P2’, P in P3’, and Y in 
P4’.   
 
Table 28: Tryptic DH5α libraries were cleaved with BACE2A.  Neither ratio yielded many peptides. 
 
Sample Id # Ratio of Protease : Library # of Scaffold Peptides # of TPP Peptides 
12 1:75 23 8 
13 1:150 24 8 
 
    
 
 
Figure 26:  A heat map was created for tryptic DH5α libraries cut with BACE2A.  The amino acids 
that were most noticeable in the 57 peptides analyzed were M in P4, W in P2, F or D in P1, P or M 
in P2’, P in P3, and Y in P4’.   
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Chymotrypsin DH5a cut with BACE2A 
A single chymotrypsin DH5α library was cut with BACE2A (Table 29).  This 
sample yielded only 30 peptides with a ratio of 1:575 
 
A heat map was generated for the chymotrypsin DH5α library cut with BACE2A 
(Fig. 27).  This heat map highlighted the amino acids occurring at higher than natural 
abundance for the 30 peptides analyzed.  The amino acids were W or D in P4, I or W in 
P3, W or G in P2, T or E in P1, V or P in P1’, L or P in P2’, F or A in P3’, and glutamine 
(Q) or I in P4’.   
 
 
Table 29:  A single chymotrypsin DH5α library was cleaved with BACE2A.  Only 30 peptides 
resulted from a ratio of 1:575.   
 
Sample Id # Ratio of Protease : Library # of Scaffold Peptides # of TPP Peptides 
6 1:575 30 27 
    
 
 
Figure 27: A chymotrypsin DH5α library was cleaved with BACE2A.  A heat map displaying the 
amino acids occurring at higher than natural abundance was generated using 30 unique peptides.  
The amino acids were W or D in P4, I or W in P3, W or G in P2, T or E in P1, V or P in P1’, L or P in 
P2’, F or A in P3’, and Q or I in P4’. 
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Discussion 
Control optimization 
Three different sets of controls were used to validate the PICS procedure in our 
lab: a tryptic DH5α library that was cut with GluC, a tryptic DH5α library cut with 
chymotrypsin, and a tryptic S2 library cut with GluC.  Each of these controls was used to 
optimize the database search parameters to match the sequenced C-terminal peptide with 
their N-terminal counterpart (Fig. 7).  Many different database search programs are 
available for use with mass spectrometric peptide sequence data.  The programs used here 
were free software or online sources recommended by the staff at the University of 
Minnesota Center for Mass Spectrometry and Proteomics.    
The two search methods used here both began by running the raw mass 
spectrometric data through SEQUEST.  SEQUEST is a search program that matches the 
mass spectrometric peptide sequence data with the corresponding protein from the 
organism’s proteome.  This software generates a list of the C-terminal portion of the 
peptides; however, the list needs to be converted to a readable format.  The two methods 
differ in the analysis of the list of peptides.  One method involves using Scaffold, a 
program used to view SEQUEST data.  This program also had the ability to limit the 
peptides by threshold tolerance for protein and peptide, so only peptides with a low rate 
of error were used.  The second method used a different program to revalidate the peptide 
list, the trans-proteomic pipeline (TPP).  TPP converts SEQUEST search data into a 
Peptide Prophet compatible format, which matches the protein sequence data to the 
known proteome of the library organism.  The final step for each method was the same.  
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The C-terminal peptide list generated was uploaded into the website created by the 
Overall lab.57  This website compares individual peptide sequences against the 
corresponding known proteome in order to determine the corresponding N-terminal 
peptide sequence.  This final list of peptides was used to generate a heat map showing the 
amino acid preferences for the different subsites normalized according to their natural 
abundance.  The two methods were optimized and then compared to determine the best 
method for database searches.   
Multiple parameters for each of these methods were optimized to confirm the 
validity of the data as well as assuring that the highest number of peptides was analyzed.  
The parameters that were optimized were: level of error tolerated, enzyme cleavage 
specified for database searches, and fixed or variable modifications.  Other parameters 
were tested, but did not have a significant impact on the results.  Parameters that resulted 
in both the highest number of peptides and the highest percent of peptides matching the 
expected values were used for analyzing the samples to determine the amino acid 
sequence cleaved by the protease of interest (Table 30).   
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 The optimal parameters for the control samples returned the highest number of 
peptide sequences along with the highest percentage of peptides matching the expected 
amino acids in P1.  Peptide, fragment, and protein tolerance define the level of error 
allowed.  The goal was to select the lowest possible level of error while avoiding false 
negatives.  This level can be increased as long as subsequent programs are used to 
revalidate the peptides.  ‘Protease specificity’ allowed the search program to set up a 
hypothetical digestion, which was used to match the mass spectrometric data entered.  
The ‘protease selected’ decreased the time of the search by limiting the possibilities for 
peptides; however, it could also result in missed peptides if the definition was too narrow.  
The possibilities for protease choices relevant to this data were partial tryptic digestion, 
C-terminal tryptic digestion, or non-specific cleavage.  Each of the controls was a tryptic 
library, but they were also cut with another protease.  Though using ‘tryptic digestion’ 
would limit and decrease the amount of time for a search, it could result in missing some 
of the peptides.  The final parameter optimized was the level of amino acid modification.  
Table 30: The optimal parameters identified using the controls.  The parameters that were optimized 
were:  level of error, enzyme cleavage specified in the database search, and fixed versus variable 
modification on K and C. 
  
Sequest Peptide Tolerance (amu)  Fragment Tolerance(amu) Cleavage Enzyme Fixed Modifications
1 1 Non-specific K, C, N-terminal
Scaffold % Protein Tolerance % Peptide Tolerance # Peptides/Protein
80 90 1
Sequest Peptide Tolerance  Fragment Tolerance (amu) Cleavage Enzyme Fixed Modifications
2 1 Non-specific K, C, N-terminal
Scaffold %  Protein Tolerance % Peptide Tolerance # Peptides/Protein
80 80 1
DH5α
Optimal Parameters for Database Analysis
S2
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 Three different modifications were added in our libraries:  thioacylation of the 
N-terminal peptide, carbamidomethylation of cysteine, and dimethylation of lysine.  The 
N-terminal modification had to be fixed, because that was how peptides cut by the 
protease of interest were separated from other peptides.  The other two modifications 
were fixed in the original protocol; however, assigning them as variable might have 
allowed for more peptides to be identified if some of the intended amino acid 
modifications did not go to completion.55  The optimal parameters identified and used to 
identify the peptide sequences cleaved by BACE1A were shown in Table 30.   
Sequence preferences for BACE1A 
Trypsin, chymotrypsin, and GluC were the three different proteases used in 
making the libraries for this experiment.  Since each of these proteases cleaves proteins 
after different classes of amino acids, the independent libraries should serve to minimize 
bias for the samples and to increase the number and variety of peptides.  The trypsin 
library resulted in the largest number of peptides and thus the most information.  
However, due to their differing specificity, chymotrypsin and GluC libraries provided 
independent data as well as confirming some of the sequences obtained from the tryptic 
libraries.   
Proteomes from DH5α (E. coli) and S2 cells (Drosophila melanogaster) were 
each used in conjunction with the proteases above to generate six independent peptide 
libraries. Both of these organisms have sequenced proteomes enabling the N-terminal 
sequences corresponding to the identified peptides to be identified through database 
searching (Fig. 7). Using both S2 and DH5α protease libraries increased the variety of 
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proteins and thus the number of different peptides in each library allowing us to gain 
more information about the preferred cleavage sequence of BACE1.   
Compiling the data for all of the BACE1A samples gave a more complete 
understanding of the preferred cleavage sequence.  Multiple amino acids are tolerated in 
each of the positions of the cleaved sequence; however, there are discernible preferences 
for certain amino acids or types of amino acids (Table 31).  Hydrophobic amino acids, 
particularly isoleucine, leucine, or valine, are seen in most positions.   
 
In the P4 position, there were multiple types of amino acids identified by PICS.  Three 
different amino acids were identified in three different libraries: aspartate, methionine, and 
tryptophan (Table 31).   Published studies and the known APP sequences cleaved by BACE1A 
have glutamate, aspartate and glutamine in P4.42  The wide variety of amino acids identified 
suggests that there is no strong preference for any particular amino acid in this position.   
Table 31: Compilation of the amino acids comprising subsite positions P4-P4’ that were 
preferred for BACE1A cleavage.  The preferred amino acids identified by the PICS 
procedure were compared to known sequences cleaved by BACE1A as well as the preferred 
sequence identified by Turner, et al. in 2001.33,42,60  Bold amino acids indicate a preference 
that is only seen with PICS data.  The outlined amino acid in P2’ indicated the mutation that 
leads to decreased BACE1 cleavage. 
 
Subsite P4 P3 P2 P1 P1' P2' P3' P4'
APP Sequence E V K M D A E F
Swedish APP mutation E V N L D A E F
Protective APP mutation E V K M D T E F
Tryptic DH5α Library D I F L Y M V A
Chymotryptic DH5α Library M Q M C G W
GluC DH5α Library W W H W S G W M I Y
Tryptic S2 Library W Y S S M
Neighbor Cooperativity V E F Q
L N
S Y V
Turner/Tang Data E Q D I/V/L D N M L F/Y M M E Q A V/I A L W A  
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For P3, there was a preference for the hydrophobic isoleucine with a slight 
preference for the aromatic tyrosine (Table 31).  Published studies have indicated a 
preference for valine and leucine in this site.42  We showed that valine and leucine affect 
the neighboring amino acids in P2 and P1.  With valine in P3, there is a cooperative 
affect between glutamate and phenylalanine in P2 and P1, respectively.  This 
cooperativity was not observed with isoleucine or valine in P3.  In fact, there was a slight 
negative cooperativity between isoleucine in P3 and phenylalanine in P1.  With 
isoleucine in P3, there were no strong cooperativity effects.  However, having leucine in 
P3 led to a preference for asparagine in P1.   
There was no strong preference for any particular amino acid in P2.  In our PICS 
data, we saw histidine and glutamine, larger, hydrophilic amino acids, as well as the 
aromatic amino acids tryptophan and tyrosine (Table 31).  Amino acids identified by 
other groups and the amino acids in the APP and mutated APP sequences were all large 
and hydrophilic.  No noticeable neighbor affects were seen for amino acids in P2 which 
supports the lack of specificity in P2.   
There was a strong preference for aromatic or hydrophobic amino acids in P1 
(Table 31).  Surprisingly, cysteine was seen for the chymotrypsin DH5α library.  
However, for all peptides identified by PICS, cysteine was modified by 
carbamidomethylation, making it much larger.  Serine was seen in both of the GluC 
DH5α and tryptic S2 libraries, but it is near the cut-off level for amino acids identified 
once normalized by their natural abundance.  Data from additional GluC DH5α and 
tryptic S2 libraries would be necessary to confirm with statistical confidence that serine is 
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indeed preferred in P1.  Neighbor affects were seen for phenylalanine and tyrosine in P1.  
With tyrosine in P1, there was a positive correlation between serine in P2 and valine in 
P2’, but these preferences were not seen with phenylalanine in P1. With phenylalanine in 
P1, the reverse cooperativity with valine in P3 was observed.  There was also a positive 
correlation for glutamate in P2 and glutamine in P3’. 
There was no strong preference for any amino acid in P1’.  Methionine, glycine, 
serine and tryptophan were all identified using PICS (Table 31).  Data from other studies 
identified glutamine, glutamate, methionine, and alanine in P1’.42  Again, this indicated 
that there were no strong preferences for a particular type of amino acid in P1’, even 
tryptophan was identified in the GluC DH5α library.     
There was a strong preference for hydrophobic or small amino acids in P2’.  The 
hydrophobic amino acids valine, isoleucine, and methionine were strongly preferred in 
P2’, though glycine and alanine were also seen here (Table 31).  Our PICS data indicated 
that valine was the most preferred amino acid in this position, a trend seen in other 
studies as well.42  A genome-wide study in Iceland revealed that a A673T mutation in the 
P2’ site of APP was protective against Alzheimer’s disease and age-related cognitive 
decline.  Our PICS data also was consistent with this decrease in BACE1 activity when 
threonine is in P2’33.  Threonine is a small, hydrophilic amino acid.  This confirmed the 
preference for hydrophobic amino acids.  No particularly significant neighbor effects 
were observed for P2’.   
There was no strong preference for any amino acid in P3’as identified with the 
PICS method (Table 31).  Different studies identified both large and small amino acids in 
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this position, indicating that the amino acid in this position does not determine cleavage 
by BACE1A.   
There were both aromatic and small amino acids identified in P4’ (Table 31) as 
well indicating no particular amino acid preference in this position for BACE1A.   
In conclusion, only the positions P3, P1, and P2’ showed strong preferences for 
certain types of amino acids in the PICS samples.  In P3, the amino acids isoleucine, 
valine, and leucine were favored.  In P1, aromatic or large amino acids were favored.  In 
P2’, valine was strongly preferred, but other amino acids such as glycine and isoleucine 
were also seen.  Only hydrophilic amino acids were identified in this position.  Neighbor 
affects indicate the following sets of amino acids:  P3: V, P2: E, P1: F, P3’: Q and P3: L, 
P1: N and P2: S, P1: Y, P2’: V (Table 31).  The optimal sequences identified using PICS 
and the cooperative neighbor affects were P3: I, P2: S, P1: Y, P1’: S, P2’: V or P3: V, P2: 
E, P1: F, P1’: M, P2’: V/I, P3’: Q.   
The BACE1A active site with an inhibitor bound is shown in Fig. 28.  There are 
no strong constraints on the size of the peptide, except in P1’.  This confirmed the amino 
acids identified with PICS, except for tryptophan seen in the GluC DH5α library.   
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Sequence preferences for BACE2A 
Compiling the data for all of the BACE2A (a close homolog of BACE1A) 
samples gives a more complete understanding of its preferred cleavage sequence.  The 
cleaved sequence tolerated many amino acids in all positions; however, there are marked 
preferences for certain amino acids or types of amino acids (Table 32).  Based on their 
homology, we predicted that there would be significant similarities between the sequence 
specificity for BACE1A and for BACE2A.  However, we were also looking for the 
differences between the cleavage sequence preferences for the two proteases.  For 
BACE2A as well as BACE1A, hydrophobic amino acids were seen in most positions.  
Neighbor effects were not seen, because there were too few peptides identified to gain a 
complete understanding of the cooperativity between neighboring amino acids.  In 
general, the results for BACE2A should be considered preliminary and interpreted 
 
Figure 28:  BACE1A active site generated using PyMOL.  The inhibitor, modified at P1 and P1’, 
is shown in red.  The protein’s active site is green.  There were no large constraints except for 
P1’.   
  81 
cautiously due to the small number of peptides analyzed in the PICS procedure for this 
enzyme. 
 
In P4, there were multiple types of amino acids identified (Table 32) indicating no 
strong preference for any amino acid in this position.  In P3, hydrophobic and aromatic 
residues were preferred, specifically isoleucine and tryptophan (Table 32).   These amino 
acids were similar to the preference found for BACE1A.No strong preference was seen 
for residues in P2 (Table 32) as small and large, aromatic amino acids were seen in this 
position.  Though the number of peptides that were analyzed was small, the lack of any 
specific type of amino acids indicated that this position may not lead to selective cleavage 
by BACE2A consistent with what was seen for BACE1A.   
In P1, there was no strong preference for any type of amino acid (Table 32).  
However, phenylalanine was seen, which was also seen for BACE1A.  Interestingly, 
acidic amino acids were also seen in P1 for both the tryptic and chymotrypsin DH5α 
libraries.  This did not coincide with the PICS data for BACE1A or with other research 
groups’ studies.41    
Table 32: Compilation of the amino acids comprising subsite positions P4-P4’ that were preferred by 
BACE2A.  The amino acids identified by the PICS procedure were compared to known sequences 
cleaved by BACE1A as well as the preferred sequence for BACE2 identified by Turner et al. in 
2002.33,41,60   
 
Subsite P4 P3 P2 P1 P1' P2' P3' P4'
APP Sequence E V K M D A E F
Swedish APP mutation E V N L D A E F
Protective APP mutation E V K M D T E F
Tryptic DH5α Library M W F D P/M P Y
Chymotryptic DH5α Library W/D W I W G T E P V P L F A Q/I
Turner/Tang Data E/Q L/I/V N D F/Y L M/L I/V E F/Y/W D W/F  
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In P1’, there was a preference for hydrophobic or small amino acids, which 
agreed with both the PICS data for BACE1A and other research groups’ studies (Table 
32).41   
In P2’, the only amino acids seen were hydrophobic (Table 32).  This preference 
was seen in BACE1A and other research groups’ studies as well.41  There was a very 
strong preference for hydrophobic amino acids in both BACE1A and BACE2A.  This 
position appeared most influential in determining cleavage by any BACE protease.  
 In P3’, there was not a strong preference for any amino acid.  Aromatic, 
hydrophobic, and small amino acids were all seen here (Table 32).  
In P4’, there was not a strong preference for any particular amino acid either.  
Glutamine, isoleucine, and tyrosine were all seen here (Table 32) indicating that this 
position does not have a strong effect on cleavage by BACE2A. 
Conclusions 
The PICS procedure can be used to gain an understanding of peptide sequences 
preferentially cleaved by any protease.  Here, the PICS data analysis method was 
optimized with three different sets of controls to validate the data obtained for the 
protease of interest.  The parameters of two different techniques used to sequence the 
N-terminal peptides and match them to the proteome of the organism to determine the 
C-terminal sequence were optimized.  The best technique with optimized parameters was 
then used to determine the amino acid sequence cleaved by BACE1A and BACE2A.  
Previous studies have revealed information about the sequence cleaved by BACE1A, but 
these studies have not been able to identify the influence of the neighboring amino acid 
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cooperativity.  This is one of the advantages of using PICS: neighbor affects can be 
investigated with this method, gaining novel information about the sequence cleaved by 
the protease of interest.   
BACE1A is an important protease involved in Alzheimer’s disease pathogenesis.  
A deeper understanding of the sequence cleaved by BACE1A would be used to 
understand the biological role of BACE1 as well as to guide the creation of inhibitors in 
the treatment of AD.  The PICS procedure identified amino acid preferences for positions 
P4-P4’, however only the positions P3, P1, and P2’ showed strong preferences.  In P3, 
the amino acids isoleucine, valine, and leucine were favored.  In P1, the aromatic amino 
acids, tyrosine and phenylalanine were favored.  In P2’, valine was strongly preferred, 
but other amino acids such as glycine and isoleucine were also seen.  Neighbor effects 
could be seen for P3 and P1, indicating that the following sets of amino acids are 
preferentially cleaved by BACE1A: P3: V, P2: E, P1: F, P3’: Q and  P3: L, P1: N and P2: 
S, P1: Y, P2’: V.  The optimal sequences identified using PICS and the cooperative 
neighbor affects were P3: I, P2: S, P1: Y, P1’: S, P2’: V or P3: V, P2: E, P1: F, P1’: M, 
P2’: V/I, P3’: Q.   
BACE2A is a homolog of BACE1A.  It prefers to cleave a similar sequence, but 
there are some indications that its sequence preference is distinct.  Initial data has been 
obtained for this protease using PICS.  However, more samples need to be analyzed to 
gain a full understanding of the preferred sequence cleaved by this protease.  Knowledge 
of the preferred sequence cleaved by the BACE family of proteases could lead to the 
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identification of novel native substrates, advancing our understanding of the function of 
this unique and interesting family of membrane-associated aspartyl proteases. 
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